<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="EN">
  <front>
    <journal-meta><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id><journal-id journal-id-type="pmc">ploscomp</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Computational Biology</journal-title></journal-title-group><issn pub-type="ppub">1553-734X</issn><issn pub-type="epub">1553-7358</issn><publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher></journal-meta>
    <article-meta><article-id pub-id-type="publisher-id">PCOMPBIOL-D-11-01777</article-id><article-id pub-id-type="doi">10.1371/journal.pcbi.1002526</article-id><article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Biology</subject>
          <subj-group>
            <subject>Computational biology</subject>
            <subj-group>
              <subject>Systems biology</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Immunology</subject>
            <subj-group>
              <subject>Immune system</subject>
              <subj-group>
                <subject>Cytokines</subject>
              </subj-group>
            </subj-group>
            <subj-group>
              <subject>Immunity</subject>
              <subj-group>
                <subject>Immunity to infections</subject>
                <subject>Inflammation</subject>
                <subject>Innate immunity</subject>
              </subj-group>
            </subj-group>
            <subj-group>
              <subject>Immune response</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Systems biology</subject>
          </subj-group>
          <subj-group>
            <subject>Theoretical biology</subject>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Computer science</subject>
          <subj-group>
            <subject>Algorithms</subject>
          </subj-group>
          <subj-group>
            <subject>Computer modeling</subject>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Mathematics</subject>
          <subj-group>
            <subject>Nonlinear dynamics</subject>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Physics</subject>
          <subj-group>
            <subject>Statistical mechanics</subject>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Immunology</subject>
          <subject>Genetics and Genomics</subject>
          <subject>Computational Biology</subject>
          <subject>Computer Science</subject>
          <subject>Physics</subject>
          <subject>Mathematics</subject>
        </subj-group>
      </article-categories><title-group><article-title>Network Topologies and Dynamics Leading to Endotoxin Tolerance and Priming in Innate Immune Cells</article-title><alt-title alt-title-type="running-head">Networks for Endotoxin Tolerance and Priming</alt-title></title-group><contrib-group>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Fu</surname>
            <given-names>Yan</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Glaros</surname>
            <given-names>Trevor</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Zhu</surname>
            <given-names>Meng</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Wang</surname>
            <given-names>Ping</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Wu</surname>
            <given-names>Zhanghan</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Tyson</surname>
            <given-names>John J.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Li</surname>
            <given-names>Liwu</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Xing</surname>
            <given-names>Jianhua</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
      </contrib-group><aff id="aff1"><label>1</label><addr-line>Department of Biological Sciences, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, United States of America</addr-line>       </aff><aff id="aff2"><label>2</label><addr-line>Interdisciplinary PhD Program of Genetics, Bioinformatics and Computational Biology, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, United States of America</addr-line>       </aff><aff id="aff3"><label>3</label><addr-line>School of Computing, Clemson University, Clemson, South Carolina, United States of America</addr-line>       </aff><contrib-group>
        <contrib contrib-type="editor" xlink:type="simple">
          <name name-style="western">
            <surname>Fraser</surname>
            <given-names>Christophe</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group><aff id="edit1">Imperial College London, United Kingdom</aff><author-notes>
        <corresp id="cor1">* E-mail: <email xlink:type="simple">lwli@vt.edu</email> (LL); <email xlink:type="simple">jxing@vt.edu</email> (JX)</corresp>
        <fn fn-type="con">
          <p>Conceived and designed the experiments: JJT LL JX. Analyzed the data: YF MZ PW ZW JX. Contributed reagents/materials/analysis tools: YF MZ PW ZW JJT JX. Wrote the paper: YF JJT LL JX. Performed computational research: YF TG MZ PW ZW JX. Performed experimental research: TG LL.</p>
        </fn>
      <fn fn-type="conflict">
        <p>The authors have declared that no competing interests exist.</p>
      </fn></author-notes><pub-date pub-type="collection">
        <month>5</month>
        <year>2012</year>
      </pub-date><pub-date pub-type="epub">
        <day>17</day>
        <month>5</month>
        <year>2012</year>
      </pub-date><volume>8</volume><issue>5</issue><elocation-id>e1002526</elocation-id><history>
        <date date-type="received">
          <day>30</day>
          <month>11</month>
          <year>2011</year>
        </date>
        <date date-type="accepted">
          <day>4</day>
          <month>4</month>
          <year>2012</year>
        </date>
      </history><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2012</copyright-year><copyright-holder>Fu et al</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><abstract>
        <p>The innate immune system, acting as the first line of host defense, senses and adapts to foreign challenges through complex intracellular and intercellular signaling networks. Endotoxin tolerance and priming elicited by macrophages are classic examples of the complex adaptation of innate immune cells. Upon repetitive exposures to different doses of bacterial endotoxin (lipopolysaccharide) or other stimulants, macrophages show either suppressed or augmented inflammatory responses compared to a single exposure to the stimulant. Endotoxin tolerance and priming are critically involved in both immune homeostasis and the pathogenesis of diverse inflammatory diseases. However, the underlying molecular mechanisms are not well understood. By means of a computational search through the parameter space of a coarse-grained three-node network with a two-stage Metropolis sampling approach, we enumerated all the network topologies that can generate priming or tolerance. We discovered three major mechanisms for priming (pathway synergy, suppressor deactivation, activator induction) and one for tolerance (inhibitor persistence). These results not only explain existing experimental observations, but also reveal intriguing test scenarios for future experimental studies to clarify mechanisms of endotoxin priming and tolerance.</p>
      </abstract><abstract abstract-type="summary">
        <title>Author Summary</title>
        <p>Inflammation is a fundamental response of animals to pathogen invasion. Among the first responders are macrophage cells, which identify and respond to multiple challenges. Their responses must be carefully regulated to kill invading pathogens without causing too much damage to host cells. Excessive activity of macrophages is associated with serious diseases like sclerosis and cancer. Macrophage responses are governed by a complex signaling network that receives cues, integrates information, implements appropriate responses and communicates with neighboring cells. This network must maintain a short-term memory of pathogen exposure. Endotoxin priming is an example. If macrophages are exposed to a small dose of bacterial toxins, they are primed to respond strongly to a second exposure to a large dose of toxin. Endotoxin tolerance, on the other hand, refers to the fact that macrophages are resistant to endotoxin challenges after a large dose pretreatment. The precise molecular mechanisms of both priming and tolerance are still poorly understood. Through computational systems biology, we have identified basic regulatory motifs for priming and for tolerance. Using information from databases and the literature, we have identified molecules that may contribute to priming and tolerance effects. Our methods are generally applicable to other types of cellular responses.</p>
      </abstract><funding-group><funding-statement>This work was supported by the National Science Foundation grant DMS-0969417 and NIH grant AI099120 (JX), NIH grant AI064414 and an American Heart Grant-in-Aid (LL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts>
        <page-count count="14"/>
      </counts></article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>Innate immune cells such as macrophages and dendritic cells constitute the first layer of host defense. Like policemen constantly patrolling the streets for criminal activity, these cells are responsible for initiating the first attack against invading pathogens <xref ref-type="bibr" rid="pcbi.1002526-Gordon1">[1]</xref>, <xref ref-type="bibr" rid="pcbi.1002526-Akira1">[2]</xref>. For example, using Toll-like receptor 4 (TLR4), macrophages recognize lipopolysaccharide (LPS, also called endotoxin), a pathogen-associated molecular pattern (PAMP) that is expressed on the outer membrane of gram-negative bacteria. Within hours of stimulation, hundreds of regulatory genes, kinases, cytokines, and chemokines are activated in sequential waves, leading to a profound inflammatory and anti-microbial response in macrophages <xref ref-type="bibr" rid="pcbi.1002526-Medzhitov1">[3]</xref>. Although effective levels of inflammation require potent cytokine production, excessive or prolonged expression can be detrimental, resulting in various immune diseases, such as autoimmunity, atherosclerosis, sepsis shock and cancers <xref ref-type="bibr" rid="pcbi.1002526-Medzhitov1">[3]</xref>, <xref ref-type="bibr" rid="pcbi.1002526-Lin1">[4]</xref>. Owing to this double-edged nature of innate immunity, living organisms have evolved a highly complex signaling network to fine-tune the expression of cytokines <xref ref-type="bibr" rid="pcbi.1002526-Ezekowitz1">[5]</xref>. A fundamental question in this field is what kinds of network topologies and dynamics in the signaling network ensure the appropriate expression of cytokines. This question is part of a larger current theme in systems biology of the design principles of biological networks. Are there small network motifs that serve as building blocks to perform complex “information processing” functions in biological signaling networks <xref ref-type="bibr" rid="pcbi.1002526-Ma1">[6]</xref>–<xref ref-type="bibr" rid="pcbi.1002526-Ma2">[12]</xref>? In this context, a systems and computational biology approach may greatly deepen our understanding in innate immunity <xref ref-type="bibr" rid="pcbi.1002526-Gilchrist1">[13]</xref>–<xref ref-type="bibr" rid="pcbi.1002526-Gardy1">[17]</xref>.</p>
      <p>Here we focus on the signaling motifs responsible for endotoxin priming and tolerance of macrophages. The interaction between host macrophages and bacterial endotoxin is arguably one of the most ancient and highly conserved phenomena in multi-cellular eukaryotic organisms <xref ref-type="bibr" rid="pcbi.1002526-Ezekowitz1">[5]</xref>. Through TLR4, LPS activates MyD88-dependent and MyD88-independent pathways, which eventually lead to the regulation of a number of downstream genes and pathways, including the mitogen-activated protein kinase (MAPK), phosphoinositide 3-kinase (PI3K), and nuclear factor κB (NFκB). The integration of these intracellular pathways leads to measured induction of pro-inflammatory mediators. Intriguingly, the induction of inflammatory mediators is also finely controlled by the quantities and prior history of LPS challenges. The latter is physiologically relevant since cells are likely repetitively exposed to stimulants in their natural environment. For example, numerous <italic>in vitro</italic> studies have found that significant induction of cytokine TNF-α and IL-6 requires at least 10 ng/mL LPS in mouse peritoneal macrophages <xref ref-type="bibr" rid="pcbi.1002526-Hirohashi1">[18]</xref>, <xref ref-type="bibr" rid="pcbi.1002526-Shnyra1">[19]</xref> and macrophage cell lines <xref ref-type="bibr" rid="pcbi.1002526-Hume2">[20]</xref>, and a high dose of LPS (100 ng/mL) is sufficient to trigger a catastrophic “cytokine storm”. Strikingly, however, the dose-response relationship can be reprogrammed by two successive treatments with LPS, to give either a reduced or an augmented expression of cytokines (<xref ref-type="fig" rid="pcbi-1002526-g001">Figure 1A</xref>). <italic>In vitro</italic>, preconditioning macrophages with a high dose (HD) of LPS (10–100 ng/mL) renders the cells much less responsive to a subsequent HD stimulation in terms of pro-inflammatory cytokine expression. This phenomenon, known as “endotoxin tolerance” or “LPS tolerance” <xref ref-type="bibr" rid="pcbi.1002526-Biswas1">[21]</xref>, is reported to last up to 3 weeks <italic>in vivo</italic> <xref ref-type="bibr" rid="pcbi.1002526-West1">[22]</xref>. On the other hand, macrophages primed by a low dose (LD) of LPS (0.05–1 ng/mL) show an augmented production of cytokine in response to a subsequent HD challenge, a phenomenon known as “LPS priming” <xref ref-type="bibr" rid="pcbi.1002526-Hirohashi1">[18]</xref>, <xref ref-type="bibr" rid="pcbi.1002526-Shnyra1">[19]</xref>, <xref ref-type="bibr" rid="pcbi.1002526-West2">[23]</xref>–<xref ref-type="bibr" rid="pcbi.1002526-Henricson1">[25]</xref>. Both priming and tolerance are present in other cells of the innate immune system including monocytes and fibroblasts, and are highly conserved from mice to humans. Our own studies on murine macrophages show both effects (<xref ref-type="fig" rid="pcbi-1002526-g001">Figure 1B</xref>).</p>
      <fig id="pcbi-1002526-g001" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pcbi.1002526.g001</object-id>
        <label>Figure 1</label>
        <caption>
          <title>Formulation of the problem.</title>
          <p>(A) Schematic illustration of <italic>in vitro</italic> experimental studies of LPS-induced tolerance and priming effect in macrophages. (B) <italic>IL-6</italic> mRNA levels of murine bone marrow derived macrophages treated with various combinations of LPS. * p&lt;0.05. (C) Abstraction of the parallel LPS associated pathways into a three-node network motif and the corresponding mathematical model based on ordinary differential equations. Refer to <xref ref-type="sec" rid="s4">Materials and Methods</xref> for details.</p>
        </caption>
        <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002526.g001" xlink:type="simple"/>
      </fig>
      <p>Endotoxin priming and tolerance may confer significant survival advantages to higher eukaryotes. Priming of innate immune cells may enable robust and expedient defense against invading pathogens, a mechanism crudely analogous to vaccination of the adaptive immune system. On the other hand, tolerance may promote proper homeostasis following robust innate immune responses. However, despite these survival advantages, endotoxin priming and tolerance are also closely associated with the pathogenesis of both chronic and acute human diseases. For example, despite the potential ability to limit pro-inflammatory cytokine production, endotoxin tolerance is responsible for the induction of immunosuppression in patients with sepsis shock, and this suppression leads to increased incidence to secondary infections and mortality <xref ref-type="bibr" rid="pcbi.1002526-West1">[22]</xref>. Endotoxin priming, on the other hand, reprograms macrophages to super-induction of proinflammatory cytokines. Increasing evidence relates this phenomenon to low-grade metabolic endotoxemia, where an elevated but physiological level of LPS in the host's bloodstream results in a higher incidence of insulin resistance, diabetes and atherosclerosis <xref ref-type="bibr" rid="pcbi.1002526-MorenoNavarrete1">[26]</xref>–<xref ref-type="bibr" rid="pcbi.1002526-Slofstra1">[29]</xref>. Augmented IL-6 expression has also been observed in human blood cells that were primed by LD and challenged by HD LPS <xref ref-type="bibr" rid="pcbi.1002526-Nakamura1">[30]</xref>.</p>
      <p>Despite the significance and intense research efforts, molecular mechanisms responsible for endotoxin priming and tolerance are not well understood, apparently due to the complex nature of intracellular signaling networks. Tolerance has been attributed to the negative regulators at multiple levels of the TLR4 signaling pathway. These include signaling molecules (<italic>e.g.</italic> SHIP, ST2, induction of IRAK-M and suppression of IRAK-1), transcriptional modulators (<italic>e.g.</italic> ATF3, p50/p50 homodimers), soluble factors (<italic>e.g.</italic> IL-10 and TGFβ), and gene-specific chromatin modifications <xref ref-type="bibr" rid="pcbi.1002526-Biswas1">[21]</xref>, <xref ref-type="bibr" rid="pcbi.1002526-Kobayashi1">[31]</xref>–<xref ref-type="bibr" rid="pcbi.1002526-Jacinto1">[38]</xref>. These negative regulators are likely to work together to drive macrophages into a transient refractory state for cytokine expression after LPS pretreatment <xref ref-type="bibr" rid="pcbi.1002526-Sly1">[33]</xref>. Molecular mechanisms for priming are rarely studied and even less well understood than tolerance. Early studies suggest that like endotoxin tolerance, both intra- and inter-cellular events may be involved in LPS priming <xref ref-type="bibr" rid="pcbi.1002526-Zhang1">[24]</xref>. Morrison and coworkers first revealed that LPS priming of cytokine TNF-α production is induced, at least in part, by a reprogrammed counterbalance between endogenous IL-10 and IL-12 in an autocrine fashion <xref ref-type="bibr" rid="pcbi.1002526-Shnyra1">[19]</xref>. However, it is still elusive exactly how the change in two counteracting soluble secretory products can contribute to the priming effect, and whether LPS priming is exclusively an intercellular event or it takes place at both intra- and inter-cellular levels.</p>
      <p>These published observations and our own new experimental results have inspired us to look for all possible mechanisms for LPS priming and tolerance. To do this, we computationally searched the high-dimensional parameter space associated with a generic mathematical model of a three-node regulatory network. The search reveals only three mechanisms accounting for priming (pathway synergy, suppressor deactivation, activator induction) and one for tolerance (inhibitor persistence). Existing experimental results support these mechanisms.</p>
      <p>In summary, our approach provides a systematic, quantitative framework for understanding numerous experimental observations, and it suggests new experimental procedures to identify the players and investigate the dynamics of priming and tolerance. Our analysis suggests that endotoxin tolerance and priming are rooted in the basic structure of the immune regulatory network: a signal often triggers synergizing pathways to ensure that sufficient responses can be elicited efficiently, as well as opposing pathways to ensure that the responses can be resolved eventually <xref ref-type="bibr" rid="pcbi.1002526-Akira1">[2]</xref>. Therefore, in addition to shedding light on LPS-induced tolerance and priming, our approach is applicable in the more general context of cross-priming and cross-talk in the signal transduction mechanisms of the innate immune system <xref ref-type="bibr" rid="pcbi.1002526-Hu1">39</xref>–<xref ref-type="bibr" rid="pcbi.1002526-Bagchi1">41</xref>.</p>
    </sec>
    <sec id="s2">
      <title>Results</title>
      <sec id="s2a">
        <title>Inducing priming and tolerance in a well-controlled experimental setting</title>
        <p>Although separate experimental studies of priming and tolerance have been carried out in many laboratories, no systematic study of both effects has been performed in the same setting. Thus, we first set out to measure priming and tolerance in the same experimental system. We used murine bone marrow derived macrophages (BMDM), which are widely used for measuring LPS responses. BMDM were treated with various combinations of LD (50 pg/mL) and HD (100 ng/mL) LPS for times indicated in <xref ref-type="fig" rid="pcbi-1002526-g001">Figure 1B</xref>. Cells were washed with PBS and fresh medium between consecutive treatments. <xref ref-type="fig" rid="pcbi-1002526-g001">Figure 1B</xref> shows that 50 pg/mL LPS induced negligible <italic>IL-6</italic>, while 100 ng/mL LPS induced robust expression of <italic>IL-6</italic> in BMDM (∼3300 fold). Consistent with previous findings, cells pre-treated for 4 h with 50 pg/mL LPS exhibited ∼4500 fold induction of <italic>IL-6</italic> when challenged with 100 ng/mL LPS, a ∼36% augmentation as compared to cells treated with 100 ng/mL LPS alone (p&lt;0.05). In contrast, cells pretreated for 4 h with 100 ng/mL LPS exhibited only ∼700 fold induction of <italic>IL-6</italic> when re-challenged with 100 ng/mL LPS, a ∼80% reduction as compared to cells treated with 100 ng/mL LPS alone (p&lt;0.05).</p>
      </sec>
      <sec id="s2b">
        <title>Identifying motifs that generate priming effect</title>
        <p><xref ref-type="fig" rid="pcbi-1002526-g001">Figure 1C</xref> shows that LPS binding to TLR4 triggers two groups of parallel pathways: MyD88-dependent and (several) MyD88-independent pathways. Together, these pathways control the expression of different but overlapping inflammatory mediators in a delicate time-dependent and dose-dependent manner. Based on these parallel pathways, we proposed a three-node model in <xref ref-type="fig" rid="pcbi-1002526-g001">Figure 1C</xref> as a minimal abstraction of the system. Each node can positively or negatively regulate the activity of itself and the other two nodes. The interactions are governed, we assume, by a standardized set of nonlinear ordinary differential equations (<xref ref-type="fig" rid="pcbi-1002526-g001">Figure 1C</xref>) for <italic>x<sub>j</sub></italic> = activity of the <italic>j</italic><sup>th</sup> node (0≤<italic>x<sub>j</sub></italic>≤1, <italic>j</italic> = 1,2,3). For a complete description of the mathematical model, see the section on <xref ref-type="sec" rid="s4">Materials and Methods</xref>. The “network topology” of the model is determined by the sign pattern of the nine interaction coefficients (−1≤<italic>ω<sub>ji</sub></italic>≤1, <italic>j</italic>,<italic>i</italic> = 1,2,3) which express the magnitude and direction of the effect of node <italic>i</italic> on node <italic>j</italic>. This is a coarse-grained model, with no distinction between intra- and inter-cellular events. For example, in a real cell the self-regulation of a node may correspond to a feedback loop involving many intermediates, including extracellular cytokines. The simplicity of the model allows full search of the 14-dimensional parameter space (although there are 18 parameters in <xref ref-type="table" rid="pcbi-1002526-t001">Table 1</xref>, four of them are held constant, as explained in <xref ref-type="sec" rid="s4">Materials and Methods</xref>). Similar three-node models have been studied in other contexts <xref ref-type="bibr" rid="pcbi.1002526-Ma1">[6]</xref>, <xref ref-type="bibr" rid="pcbi.1002526-Yang1">[42]</xref>, <xref ref-type="bibr" rid="pcbi.1002526-Yao1">[43]</xref>.</p>
        <table-wrap id="pcbi-1002526-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1002526.t001</object-id><label>Table 1</label><caption>
            <title>Description of modeling parameters.</title>
          </caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pcbi-1002526-t001-1" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002526.t001" xlink:type="simple"/><table>
            <colgroup span="1">
              <col align="left" span="1"/>
              <col align="center" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <td align="left" colspan="1" rowspan="1">Parameter</td>
                <td align="left" colspan="1" rowspan="1">Description</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" colspan="1" rowspan="1">
                  <italic>x<sub>j</sub></italic>
                </td>
                <td align="left" colspan="1" rowspan="1">Concentration (or activity) of species <italic>j</italic></td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">
                  <italic>γ<sub>j</sub></italic>
                </td>
                <td align="left" colspan="1" rowspan="1">Time scale of <italic>x<sub>j</sub></italic> dynamics</td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">
                  <italic>ω<sub>ji</sub></italic>
                </td>
                <td align="left" colspan="1" rowspan="1">Regulation strength of <italic>x<sub>i</sub></italic> on <italic>x<sub>j</sub></italic></td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">
                  <italic>ω<sub>j0</sub></italic>
                </td>
                <td align="left" colspan="1" rowspan="1">Activation threshold of <italic>x<sub>j</sub></italic></td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">
                  <italic>σ<sub>j</sub></italic>
                </td>
                <td align="left" colspan="1" rowspan="1">Nonlinearity of the regulation relation associated to species <italic>x<sub>j</sub></italic></td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">
                  <italic>S<sub>j</sub></italic>
                </td>
                <td align="left" colspan="1" rowspan="1">External signal strength acting on <italic>x<sub>j.</sub></italic> (<italic>S</italic><sub>3</sub> = 0, <italic>S</italic><sub>1</sub> = <italic>S</italic><sub>2</sub>)</td>
              </tr>
            </tbody>
          </table></alternatives></table-wrap>
        <p>We searched the 14-dimensional parameter space of the model for priming and then for tolerance. The behavior of the model is defined as “priming” if the maximum level of the output variable <italic>x</italic><sub>3</sub> under the priming dose (step 3 in <xref ref-type="fig" rid="pcbi-1002526-g001">Figure 1A</xref>) is small (<italic>x</italic><sub>3</sub>&lt;0.3), but with the subsequent high dose (step 4 in <xref ref-type="fig" rid="pcbi-1002526-g001">Figure 1A</xref>) <italic>x</italic><sub>3</sub> is at least 50% higher than the level reached without priming (step 1 in <xref ref-type="fig" rid="pcbi-1002526-g001">Figure 1A</xref>). Similarly, for “tolerance” the maximum level of <italic>x</italic><sub>3</sub> must be high enough under the first HD exposure (<italic>x</italic><sub>3</sub>&gt;0.3) but less intense by at least 50% under the second HD challenge (step 2 in <xref ref-type="fig" rid="pcbi-1002526-g001">Figure 1A</xref>). Precise criteria for priming and tolerance are provided in <xref ref-type="supplementary-material" rid="pcbi.1002526.s009">Table S1</xref>. Brute force search of the parameter space is impractical. Unbiased searching results in &lt;1000 parameter sets exhibiting priming after 10<sup>8</sup> Monte Carlo steps. Noticing that parameter sets giving priming or tolerance (called “good sets” for convenience) are clustered into a small number of isolated regions in parameter space, we designed a two-stage sampling procedure. First we perform a Metropolis search slightly biased for good sets. Next, to identify any isolated regions of parameter space where good sets are clustered, we analyzed the good sets using K-means clustering and Principal Component Analysis (see <xref ref-type="supplementary-material" rid="pcbi.1002526.s012">Text S1</xref>). The good sets then serve as seeds in the second stage of sampling, which restricts Metropolis searching to each local region of good sets. This two-stage procedure allows us to search the parameter space thoroughly and to obtain good-set samples that are large enough for statistical analysis. The overall procedure is illustrated schematically in <xref ref-type="supplementary-material" rid="pcbi.1002526.s001">Figure S1</xref> and discussed in <xref ref-type="supplementary-material" rid="pcbi.1002526.s012">Text S1</xref>.</p>
      </sec>
      <sec id="s2c">
        <title>Three basic mechanisms for the priming effect of LPS</title>
        <p>By trial-and-error, we found that the two experimentally measurable quantities, Δ<italic>x</italic><sub>1</sub> and Δ<italic>x</italic><sub>2</sub> (see <xref ref-type="fig" rid="pcbi-1002526-g002">Figure 2A</xref>), are effective in dividing the “good” parameter sets into three regions (see <xref ref-type="fig" rid="pcbi-1002526-g002">Figure 2B</xref>). Here Δ<italic>x</italic><sub>1</sub> = maximum difference between <italic>x</italic><sub>1</sub> during the LD priming stage and the steady state value of <italic>x</italic><sub>1</sub> in the absence of any stimulus, and Δ<italic>x</italic><sub>2</sub> = difference between the maximum values of <italic>x</italic><sub>2</sub> during the HD period with and without the priming pretreatment (<xref ref-type="fig" rid="pcbi-1002526-g002">Figure 2A</xref>). Further analysis (discussed below) revealed that the three groups correspond to three distinct priming mechanisms: “Pathway Synergy” (PS), “Activator Induction” (AI), and “Suppressor Deactivation” (SD). All AI and PS parameter sets show considerable increase in <italic>x</italic><sub>2</sub> (&gt;0.1) after the priming stage, while SD does not (<xref ref-type="supplementary-material" rid="pcbi.1002526.s002">Figure S2</xref>).</p>
        <fig id="pcbi-1002526-g002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pcbi.1002526.g002</object-id>
          <label>Figure 2</label>
          <caption>
            <title>Three priming mechanisms revealed by time-course patterns.</title>
            <p>(A) Definition of clustering axis Δ<italic>x</italic><sub>1</sub> and Δ<italic>x</italic><sub>2</sub>. Δ<italic>x</italic><sub>1</sub> refers to the maximum difference between <italic>x</italic><sub>1</sub> during the LD priming stage and the steady state value of <italic>x</italic><sub>1</sub> in the absence of any stimulus. Δ<italic>x</italic><sub>2</sub> refers to the difference between the maximum values of <italic>x</italic><sub>2</sub> during the HD period with and without priming pretreatment. (B) The time courses of the priming data sets naturally divide into three clusters, corresponding to three priming mechanisms. The pie chart shows the relative frequencies of the priming mechanisms among all the priming parameter sets.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002526.g002" xlink:type="simple"/>
        </fig>
        <p>To characterize these priming mechanisms, we next examined the parameter sets within each group for shared topological features. The topology of a regulatory motif is defined as the sign pattern (+, − or 0) of the nine interaction coefficients, <italic>ω<sub>ji</sub></italic>, with the proviso that <italic>ω<sub>ji</sub></italic>'s in the interval [−0.1, 0.1] are set = 0. We define a backbone motif as the simplest network topology that is shared by most of the good priming sets in each group and that is able to generate a priming effect on its own. Therefore, a backbone motif represents a core network structure in each group. <xref ref-type="fig" rid="pcbi-1002526-g003">Figure 3A</xref> shows that each group has its unique backbone motif(s), directly revealing different priming mechanisms in each group. <xref ref-type="supplementary-material" rid="pcbi.1002526.s003">Figure S3</xref> and <xref ref-type="supplementary-material" rid="pcbi.1002526.s012">Text S1</xref> provide detailed statistical methods used to identify the backbone motifs. The two-dimensional parameter histograms in <xref ref-type="supplementary-material" rid="pcbi.1002526.s004">Figure S4</xref> provide further support for the backbone motifs we have identified.</p>
        <fig id="pcbi-1002526-g003" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pcbi.1002526.g003</object-id>
          <label>Figure 3</label>
          <caption>
            <title>Details of the three priming mechanisms.</title>
            <p>(A) Backbone motifs (topological features shared by most of the good parameter sets) of each priming mechanism (see <xref ref-type="supplementary-material" rid="pcbi.1002526.s003">Figure S3</xref> and <xref ref-type="supplementary-material" rid="pcbi.1002526.s012">Text S1</xref> for details). The width of a line is proportional to the mean value of the corresponding <italic>ω<sub>ji</sub></italic> among data sets under each priming mechanism. The “slow” and “fast” time scales reflect the values of γ<italic><sub>j</sub></italic> in comparison to γ<sub>3</sub> = 1. (B–D) Typical time courses and corresponding phase space trajectories with or without LD pretreatment. Bistable results for AI and SD are shown in <xref ref-type="supplementary-material" rid="pcbi.1002526.s005">Figure S5</xref>.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002526.g003" xlink:type="simple"/>
        </fig>
        <p><xref ref-type="fig" rid="pcbi-1002526-g003">Figure 3B–D</xref> shows typical time-courses and state-space trajectories for the three priming mechanisms (see <xref ref-type="supplementary-material" rid="pcbi.1002526.s010">Table S2</xref> for the parameter values used to generate this figure).</p>
        <p><bold><italic>Pathway Synergy</italic></bold><bold> (</bold><bold><italic>PS</italic></bold><bold>):</bold> As shown in the upper left panel of <xref ref-type="fig" rid="pcbi-1002526-g003">Figure 3A</xref>, the backbone motif of PS mechanism contains both pathways through <italic>x</italic><sub>1</sub> and <italic>x</italic><sub>2</sub> activating <italic>x</italic><sub>3</sub>. Under a single HD, the faster pathway through <italic>x</italic><sub>1</sub> prevents activation of <italic>x</italic><sub>2</sub>, either directly or through <italic>x</italic><sub>3</sub>. Consequently there is no synergy between the two pathways after a single HD. With LD pretreatment, however, <italic>x</italic><sub>2</sub> is partially activated. During the following HD treatment, this partial activation allows <italic>x</italic><sub>2</sub> to increase significantly, either transiently (<xref ref-type="fig" rid="pcbi-1002526-g003">Figure 3B</xref> left panel, called “monostable”) or persistently (<xref ref-type="fig" rid="pcbi-1002526-g003">Figure 3B</xref> right panel, called “bistable”), despite inhibition from <italic>x</italic><sub>1</sub> and/or <italic>x</italic><sub>3</sub>. Simultaneous activation of both pathways leads to synergy between them and a priming effect for <italic>x</italic><sub>3</sub>.</p>
        <p><bold><italic>Activator Induction</italic></bold><bold> (</bold><bold><italic>AI</italic></bold><bold>):</bold> In the backbone motif (see upper right panel of <xref ref-type="fig" rid="pcbi-1002526-g003">Figure 3A</xref>), the pathway through <italic>x</italic><sub>1</sub> (with high activation threshold) inhibits <italic>x</italic><sub>3</sub>, whereas the pathway through <italic>x</italic><sub>2</sub> (with a low activation threshold) activates <italic>x</italic><sub>3</sub>. Consequently, under a single HD, the two pathways work against each other to prevent full activation of <italic>x</italic><sub>3</sub>. A LD pretreatment partially activates <italic>x</italic><sub>2</sub> without significantly affecting <italic>x</italic><sub>1</sub>. Then, during the following HD treatment, <italic>x</italic><sub>2</sub> gets a head start on <italic>x</italic><sub>1</sub> to induce greater activation of <italic>x</italic><sub>3</sub> than observed under a single HD. The activation of <italic>x</italic><sub>3</sub> can be either transient (monostable) or persistent (bistable), as illustrated in <xref ref-type="fig" rid="pcbi-1002526-g003">Figure 3C</xref> and <xref ref-type="supplementary-material" rid="pcbi.1002526.s005">Figure S5A</xref>.</p>
        <p><bold><italic>Suppressor Deactivation</italic></bold><bold> (</bold><bold><italic>SD</italic></bold><bold>):</bold> In this case there are two backbone motifs slightly different from each other (the lower panel of <xref ref-type="fig" rid="pcbi-1002526-g003">Figure 3A</xref>). Both motifs contain an inhibition pathway (<italic>x</italic><sub>1</sub> ―| <italic>x</italic><sub>3</sub>) with slow dynamics and low sensitivity to LPS, and an activation pathway (<italic>x</italic><sub>2</sub>→<italic>x</italic><sub>3</sub>) with fast dynamics and high sensitivity to LPS. The basal level of the suppressor <italic>x</italic><sub>1</sub> is relatively high, which is typical of some suppressors (<italic>e.g.</italic> TOLLIP, TRAILR, PI3K and nuclear receptors) that are constitutively expressed in macrophages to prevent unwanted expression of downstream pro-inflammatory genes under non-stimulated conditions <xref ref-type="bibr" rid="pcbi.1002526-Necela1">[44]</xref>, <xref ref-type="bibr" rid="pcbi.1002526-Liew1">[45]</xref>. Compared to AI, in this case the LD pretreatment decreases the level of suppressor <italic>x</italic><sub>1</sub>, through direct inhibition of <italic>x</italic><sub>1</sub> by <italic>x</italic><sub>2</sub>. The basic SD effect is amplified either by <italic>x</italic><sub>2</sub> self-activation (backbone motif I) or by negative feedback from <italic>x</italic><sub>3</sub> to <italic>x</italic><sub>1</sub> (backbone motif II). As before, the activation of <italic>x</italic><sub>3</sub> can be either transient (monostable) or persistent (bistable), as illustrated in <xref ref-type="fig" rid="pcbi-1002526-g003">Figure 3B</xref> and <xref ref-type="supplementary-material" rid="pcbi.1002526.s005">Figure S5B</xref>.</p>
      </sec>
      <sec id="s2d">
        <title>Combined backbone motifs may enhance the robustness of the priming effect</title>
        <p>Each of these groups contains many different network topologies (187 in PS, 139 in SD, and 82 in AI). Taking SD as an example, <xref ref-type="fig" rid="pcbi-1002526-g004">Figure 4A</xref> shows the sorted density distribution of the 139 unique topologies represented by the SD parameter sets. The top 7 of these topologies (<xref ref-type="fig" rid="pcbi-1002526-g004">Figure 4B</xref>) comprise 31% of all the SD parameter sets. Consistent with other studies <xref ref-type="bibr" rid="pcbi.1002526-Ma1">[6]</xref>, <xref ref-type="bibr" rid="pcbi.1002526-Yao1">[43]</xref>, the most highly represented topologies contain more links than the corresponding backbone motif, indicating that additional links may increase the robustness of a network. While the two backbone motifs rank Top 27 and Top 10 respectively (<xref ref-type="fig" rid="pcbi-1002526-g004">Figure 4B</xref>), their combination ranks Top 4. The Venn diagram in <xref ref-type="fig" rid="pcbi-1002526-g004">Figure 4C</xref> shows that of the 93% of SD parameter sets that contain at least one of the two backbone motifs, 64% contain both. Notice that the two backbone motifs use different helpers to deactivate the suppressor (<italic>x</italic><sub>1</sub>) under LD, the combination of motifs (Top 4) integrates both helpers so that deactivation of the suppressor can be enhanced (<xref ref-type="fig" rid="pcbi-1002526-g004">Figure 4C</xref>). The results of a similar analysis applied to PS and AI mechanisms are given in <xref ref-type="supplementary-material" rid="pcbi.1002526.s007">Figure S7</xref>.</p>
        <fig id="pcbi-1002526-g004" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pcbi.1002526.g004</object-id>
          <label>Figure 4</label>
          <caption>
            <title>Analysis of the robust priming topologies in the SD mechanism.</title>
            <p>(A) 139 unique topologies under SD mechanism sorted by topology density (see <xref ref-type="supplementary-material" rid="pcbi.1002526.s006">Figure S6</xref> and <xref ref-type="supplementary-material" rid="pcbi.1002526.s012">Text S1</xref> for detailed discussion). (B) The highest seven density topologies and the backbone motifs. Line widths are proportional to the mean value of samples of the corresponding topology. Dashed lines denote the additional link present in the top topologies but absent in the backbone motif. (C) Combination of the two backbone motifs is common in the SD data sets. 93% of SD data sets are found to contain either Motif I or Motif II as the backbone motif. Among them, 64% contain both Motif I and Motif II.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002526.g004" xlink:type="simple"/>
        </fig>
        <p>Additionally, in the <xref ref-type="supplementary-material" rid="pcbi.1002526.s008">Figure S8</xref> and <xref ref-type="supplementary-material" rid="pcbi.1002526.s012">Text S1</xref>, we discuss a parameter compensation effect that further expands the priming region in the parameter space.</p>
      </sec>
      <sec id="s2e">
        <title>Slow inhibitor relaxation dynamics is essential for the induction of tolerance</title>
        <p>We used the 3-node model to search for endotoxin-tolerance motifs. The tolerance effect requires that pro-inflammatory cytokine expression (<italic>x</italic><sub>3</sub>) is markedly reduced (by at least 1.5 fold) under two sequential HD treatments with LPS, compared to the level induced by a single HD (see <xref ref-type="supplementary-material" rid="pcbi.1002526.s009">Table S1</xref> for details). Over 1660 unique topologies are found to give a tolerance effect (<xref ref-type="fig" rid="pcbi-1002526-g005">Figure 5A</xref>), indicating that the requirements for tolerance are much lower than for priming. A typical time course (<xref ref-type="fig" rid="pcbi-1002526-g005">Figure 5B</xref>, left panel) highlights the essential dynamical requirement for tolerance — to sustain a sufficiently high level of inhibitor (<italic>x</italic><sub>1</sub> in this case) after the first HD of LPS so that <italic>x</italic><sub>3</sub> is less responsive to the second HD stimulus. The effect is transient: if the second HD stimulus is delayed long enough for the suppressor to return to its basal level, then the tolerance effect is lost (<xref ref-type="fig" rid="pcbi-1002526-g005">Figure 5B</xref>, right panel). This “memory” effect has been noticed in other modeling studies <xref ref-type="bibr" rid="pcbi.1002526-Day1">[46]</xref>–<xref ref-type="bibr" rid="pcbi.1002526-An1">[49]</xref> and is consistent with experimental observations. For example, the tolerance status of IL-6 is reported to persist for 48 h after the initial HD of LPS, but beyond this time a re-challenge started to recover the expression of IL-6 <xref ref-type="bibr" rid="pcbi.1002526-Foster1">[34]</xref>. <xref ref-type="fig" rid="pcbi-1002526-g005">Figure 5C</xref> shows two backbone motifs that support temporary persistence of the inhibitor: by slow removal or by positive auto-regulation of the inhibitor.</p>
        <fig id="pcbi-1002526-g005" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pcbi.1002526.g005</object-id>
          <label>Figure 5</label>
          <caption>
            <title>Analysis of the tolerance data sets.</title>
            <p>(A) The unique topologies generating a tolerance effect sorted by topology density. (B) Typical time courses shown with normal (left panel) or elongated (right panel) gap period between the two doses. Solid line: time course tracking the dynamics of the system under the first HD stimulation, in gap period and under a second HD stimulation. Dashed line: time course tracking the dynamics under a single HD treatment; in this case the system is treated with no LPS during the otherwise first HD period. (C) Distribution of the change of <italic>x</italic><sub>1</sub> level due to the initial HD stimulation reveals two mechanisms to achieve slow relaxation dynamics in the inhibitor (left panel) and the corresponding two backbone motif (right panel).</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002526.g005" xlink:type="simple"/>
        </fig>
      </sec>
      <sec id="s2f">
        <title>The dosing scenarios for priming and tolerance are well separated</title>
        <p>It is of interest to ask whether priming and tolerance can be observed in a single 3-node network given the corresponding dosing conditions. It turns out that about 11% of the priming motifs exhibit tolerance as well, and most of them belong to the SD or the AI mechanism. <xref ref-type="fig" rid="pcbi-1002526-g006">Figure 6A</xref> shows qualitatively the dose-response relationship for priming and tolerance in a typical network motif. First, both priming and tolerance require a relatively large second dose (&gt;0.5). Second, the dosing regions for priming and tolerance are well separated. A low first dose (0.1–0.4) leads to priming while a higher one (0.5–1) leads to tolerance. There exists a range separating the priming and the tolerance region where neither are observed.</p>
        <fig id="pcbi-1002526-g006" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pcbi.1002526.g006</object-id>
          <label>Figure 6</label>
          <caption>
            <title>Phase diagrams for priming and tolerance in a typical network motif.</title>
            <p>(A) Regions of dosing conditions for tolerance and priming are well separated. (B) Both priming and tolerance effects are affected by the duration of two sequential treatments (with the gap period between two doses being fixed). (C) Priming and tolerance are also affected by the duration of the gap between two doses. Very long gaps fail to exhibit either priming or tolerance.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002526.g006" xlink:type="simple"/>
        </fig>
      </sec>
      <sec id="s2g">
        <title>Signaling durations affect the induction of priming and tolerance</title>
        <p>Most experimental studies of priming and tolerance are performed with fixed durations of the three time periods (T<sub>1</sub>, T<sub>2</sub>, and T<sub>3</sub> in <xref ref-type="fig" rid="pcbi-1002526-g001">Figure 1A</xref>). Time-course measurements are rarely reported. The phase diagrams in <xref ref-type="fig" rid="pcbi-1002526-g006">Figure 6B &amp; C</xref> show how varying each time period can affect the induction of priming and tolerance in a typical network motif. Altogether, these results reveal important dynamical requirement in priming and tolerance and suggest systematic studies in real biological experiments.</p>
        <p>The left panel of <xref ref-type="fig" rid="pcbi-1002526-g006">Figure 6B</xref> shows the effects of varying stimulus durations (T<sub>1</sub> and T<sub>3</sub>) at fixed gap duration (T<sub>2</sub>). To generate priming, T<sub>1</sub> must be sufficiently long, while T<sub>3</sub> can be relatively short (left panel of <xref ref-type="fig" rid="pcbi-1002526-g006">Figure 6B</xref>). A sufficient priming duration is crucial because the system utilizes this time to activate/deactivate the regulatory pathway with slower dynamics, <italic>i.e.</italic>, the synergizing pathway in PS and the suppressor pathway in SD. Therefore, if T<sub>1</sub> is too short, one may erroneously conclude that priming does not exist in the system. On the other hand, tolerance is less dependent on T<sub>1</sub> (right panel of <xref ref-type="fig" rid="pcbi-1002526-g006">Figure 6B</xref>).</p>
        <p><xref ref-type="fig" rid="pcbi-1002526-g006">Figure 6C</xref> shows results when all durations are varied under the constraint T<sub>1</sub> = T<sub>3</sub>. In this case, both priming and tolerance require that T<sub>2</sub> is sufficiently short compared to the time required for the system to relax to its basal state after the first stimulus. This result reveals priming and tolerance as essentially the result of cellular memory of the first stimulation.</p>
      </sec>
    </sec>
    <sec id="s3">
      <title>Discussion</title>
      <p>Using a simple yet flexible model of cellular signaling pathways, we have carried out a systematic study of the topological and dynamic requirements for endotoxin priming and tolerance in cells of the innate immune system. Our study reveals that the phenomena of priming and tolerance can be attributed to a few characteristic network motifs (called “backbone” motifs) that are simple yet effective combinations of feed-forward loops, negative feedback signals, and auto-activation. In addition to reconciling the limited available experimental data on endotoxin priming and tolerance, our models suggest novel, testable hypotheses regarding the molecular mechanisms responsible for these effects.</p>
      <sec id="s3a">
        <title>Essential modalities for priming and tolerance</title>
        <p>Our <italic>in silico</italic> analysis identifies three basic mechanisms for priming (<xref ref-type="fig" rid="pcbi-1002526-g007">Figure 7</xref>). In these mechanisms two pathways interact either constructively (pathway synergy–PS) or destructively (activator induction–AI, suppressor deactivation–SD). Compared to the response of these systems to a single high dose (HD) of LPS, a priming dose of LPS modifies the relative phases of the two pathways so as to strengthen pathway synergy (for PS mechanism) or weaken pathway interference (for SD and AI mechanisms).</p>
        <fig id="pcbi-1002526-g007" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pcbi.1002526.g007</object-id>
          <label>Figure 7</label>
          <caption>
            <title>Schematic illustration of constructive (PS) and destructive (AI, SD) pathway interference leading to priming effect.</title>
            <p>PS results from the activation of the LD-responsive pathway (<italic>x</italic><sub>2</sub>) which cooperates with the other HD-responsive pathway (<italic>x</italic><sub>1</sub>) to boost cytokine expression in response to the following HD stimulus. AI results from activating a LD-responsive pathway (<italic>x</italic><sub>2</sub>), which cancels the inhibition coming from the other HD-responsive inhibitor (<italic>x</italic><sub>1</sub>) during the HD stage. SD results from deactivating a constitutively expressed suppressor (<italic>x</italic><sub>1</sub>) during the priming stage. Red line with arrow head: activation pathway. Blue line with bar head: inhibition pathway. Line width denotes strength of the pathway controlling the downstream cytokine expression.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002526.g007" xlink:type="simple"/>
        </fig>
        <p>In this work we define the priming effect as a response of <italic>x</italic><sub>3</sub> that is at least 50% higher with priming than without. The threshold of 50% is consistent with experimental observations <xref ref-type="bibr" rid="pcbi.1002526-West2">[23]</xref>, <xref ref-type="bibr" rid="pcbi.1002526-Henricson1">[25]</xref>, but to be sure that our conclusions are robust, we also performed the computational analysis at two other thresholds: 30% augmentation or 70% augmentation (i.e., <italic>λ</italic> = 1.3 or <italic>λ</italic> = 1.7 in <xref ref-type="supplementary-material" rid="pcbi.1002526.s009">Table S1</xref>). In both cases we obtained results similar to those shown in <xref ref-type="fig" rid="pcbi-1002526-g002">Figure 2B</xref>, corresponding to the three priming mechanisms, although the exact percentage of each priming mechanism among the data sets varies with the priming threshold.</p>
        <p>The priming effect may be viewed as a primitive counterpart of the more sophisticated memory mechanisms of the adaptive immune system. For a limited period of time after exposure to a weak stimulus, the system is prepared to launch a stronger response to a second exposure to the (same or another) stimulus <xref ref-type="bibr" rid="pcbi.1002526-Hu1">[39]</xref>, <xref ref-type="bibr" rid="pcbi.1002526-Taniguchi1">[50]</xref>. On the other hand, tolerance reflects a transient refractory status to produce inflammatory cytokines due to the memory of an earlier exposure.</p>
      </sec>
      <sec id="s3b">
        <title>Supporting experimental evidences at intra- and inter-cellular levels</title>
        <p>The actual molecular and cellular networks responsible for endotoxin priming and tolerance are highly complex, involving both intra- and inter-cellular signaling modalities. A combination of priming/tolerance motifs most likely coexist in real signaling networks, and their interactions will determine the specific properties of the priming/tolerance effect <italic>in vivo</italic>. LPS is known to activate multiple intracellular pathways through TLR4, including MyD88-dependent, TRIF-dependent pathways <xref ref-type="bibr" rid="pcbi.1002526-Takeda1">[51]</xref>. Cross-talk among these pathways may be differentially modulated by low <italic>vs.</italic> high dosages of LPS, and thus contribute to differential priming and tolerance <xref ref-type="bibr" rid="pcbi.1002526-Li1">[37]</xref>, <xref ref-type="bibr" rid="pcbi.1002526-Laird1">[52]</xref>, <xref ref-type="bibr" rid="pcbi.1002526-Maitra1">[53]</xref>.</p>
        <p>Endotoxin tolerance has drawn significant attention in the past due to its relevance to septic shock. Existing literature reveals the involvement of multiple negative regulators (SHIP, ST2, IL-10, IRAK-M, SOCS1) at either intracellular or intercellular levels. Many of them are shown to be persistently elevated during endotoxin tolerance, a key feature (confirmed by our systems analysis) creating a refractory state that suppresses the expression of pro-inflammatory mediators (see <xref ref-type="table" rid="pcbi-1002526-t002">Table 2</xref>). For example, SHIP and ST2 are documented to have very slow degradation rates. On the other hand, negative regulators with faster turn-over rates, such as A20 and MKP1 (induced between 2–4 h by LPS), are known not to be required for LPS tolerance <xref ref-type="bibr" rid="pcbi.1002526-Biswas1">[21]</xref>, <xref ref-type="bibr" rid="pcbi.1002526-vantVeer1">[54]</xref>.</p>
        <table-wrap id="pcbi-1002526-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pcbi.1002526.t002</object-id><label>Table 2</label><caption>
            <title>Experimental evidence supporting the proposed tolerance mechanism.</title>
          </caption><!--===== Grouping alternate versions of objects =====--><alternatives><graphic id="pcbi-1002526-t002-2" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002526.t002" xlink:type="simple"/><table>
            <colgroup span="1">
              <col align="left" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
              <col align="center" span="1"/>
            </colgroup>
            <thead>
              <tr>
                <td align="left" colspan="1" rowspan="1">Molecular Candidate</td>
                <td align="left" colspan="1" rowspan="1">Inhibition Target</td>
                <td align="left" colspan="1" rowspan="1">Persistent Strategy</td>
                <td align="left" colspan="1" rowspan="1">Reported Evidence</td>
                <td align="left" colspan="1" rowspan="1">Reference</td>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td align="left" colspan="1" rowspan="1">IRAK-M</td>
                <td align="left" colspan="1" rowspan="1">IRAK-1 and IRAK-4 signaling</td>
                <td align="left" colspan="1" rowspan="1">Slow time scale</td>
                <td align="left" colspan="1" rowspan="1">Both mRNA and protein level of IRAK-M kept increased until 24 h with LPS stimulation.</td>
                <td align="left" colspan="1" rowspan="1">
                  <xref ref-type="bibr" rid="pcbi.1002526-Kobayashi1">[31]</xref>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">SHIP</td>
                <td align="left" colspan="1" rowspan="1">NFκB pathway</td>
                <td align="left" colspan="1" rowspan="1">Slow time scale; Positive auto-regulation of upstream regulator</td>
                <td align="left" colspan="1" rowspan="1">Slow but sustained production of SHIP (peaked at 24 h and remained high until 48 h with LPS stimulation), regulated via autocrine-acting TGF-β; long half-life of SHIP protein.</td>
                <td align="left" colspan="1" rowspan="1">
                  <xref ref-type="bibr" rid="pcbi.1002526-Sly1">[33]</xref>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">SOCS1 (under debate)</td>
                <td align="left" colspan="1" rowspan="1">IRAK and NFκB pathway</td>
                <td align="left" colspan="1" rowspan="1">Slow time scale</td>
                <td align="left" colspan="1" rowspan="1">SOCS1 mRNA levels remains detectable 24 h post LPS stimulation.</td>
                <td align="left" colspan="1" rowspan="1">
                  <xref ref-type="bibr" rid="pcbi.1002526-Nakagawa1">[69]</xref>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">ST2</td>
                <td align="left" colspan="1" rowspan="1">MyD88 and Mal</td>
                <td align="left" colspan="1" rowspan="1">Slow time scale</td>
                <td align="left" colspan="1" rowspan="1">ST2 is induced at 4 h and lasts until 48 h with LPS stimulation.</td>
                <td align="left" colspan="1" rowspan="1">
                  <xref ref-type="bibr" rid="pcbi.1002526-Brint1">[32]</xref>
                </td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">IL-10 (required but not necessary for tolerance)</td>
                <td align="left" colspan="1" rowspan="1">MyD88-dependent pathway (IRAK, TRAF6)</td>
                <td align="left" colspan="1" rowspan="1">Slow time scale; Positive autoregulation</td>
                <td align="left" colspan="1" rowspan="1">Significant level of IL-10 was detected with prolonged (24 h) LPS stimulation, and the level is sustained until 48 h. The IL-10-activated STAT3 is required for efficient induction of IL-10.</td>
                <td align="left" colspan="1" rowspan="1"><xref ref-type="bibr" rid="pcbi.1002526-Chang1">[35]</xref>, <xref ref-type="bibr" rid="pcbi.1002526-Staples1">[70]</xref>–<xref ref-type="bibr" rid="pcbi.1002526-deWaalMalefyt1">[72]</xref></td>
              </tr>
              <tr>
                <td align="left" colspan="1" rowspan="1">DNA methylation and chromatin remodeling</td>
                <td align="left" colspan="1" rowspan="1">Proinflammatory cytokine (TNF-α) gene expression</td>
                <td align="left" colspan="1" rowspan="1">Slow time scale</td>
                <td align="left" colspan="1" rowspan="1">Sustained methylation of H3 (lys9), increased and sustained binding of RelB (as transcriptional repressor) on TNF-α promoter in tolerant THP-1 cells.</td>
                <td align="left" colspan="1" rowspan="1"><xref ref-type="bibr" rid="pcbi.1002526-ElGazzar1">[36]</xref>, <xref ref-type="bibr" rid="pcbi.1002526-Chen1">[73]</xref></td>
              </tr>
            </tbody>
          </table></alternatives></table-wrap>
        <p>In terms of priming, our <italic>in silico</italic> results are consistent with limited experimental data regarding potential molecular mechanisms. For example (<xref ref-type="fig" rid="pcbi-1002526-g008">Figure 8A</xref>), IL-12 and IL-10 are differentially induced by low <italic>vs.</italic> high dose LPS, and subsequently serve as autocrine mediators to modulate LPS priming <xref ref-type="bibr" rid="pcbi.1002526-Shnyra1">[19]</xref>. <xref ref-type="fig" rid="pcbi-1002526-g008">Figure 8B</xref> provides a second example. Low dose LPS (50 pg/mL) can selectively activate transcription factor C/EBPδ, yet fails to activate the classic NFκB pathway <xref ref-type="bibr" rid="pcbi.1002526-Maitra1">[53]</xref>. Hence, by a pathway synergy motif, the selective activation of C/EBPδ by low dose LPS may synergize with NFκB under the subsequent high dose to induce the priming effect. While the removal of nuclear repressor by low dose LPS is reported <xref ref-type="bibr" rid="pcbi.1002526-Maitra1">[53]</xref>, further evidence for the predicted suppressor deactivation mechanism awaits additional, targeted experimentation. In this context, one needs to be aware that our predicted network motifs are simple topologies that have the potential to generate priming or tolerance, within proper parameter ranges. Our predictions warrant further experimental studies to determine the physiologically relevant ranges of signaling parameters required for priming and tolerance.</p>
        <fig id="pcbi-1002526-g008" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pcbi.1002526.g008</object-id>
          <label>Figure 8</label>
          <caption>
            <title>Example regulatory networks supporting the priming mechanisms.</title>
            <p>(A) The AI mechanism is consistent with observed intra- and inter-cellular molecular mechanisms for LPS priming, based on counterbalanced IL-10 and IL-12 signaling <xref ref-type="bibr" rid="pcbi.1002526-Shnyra1">[19]</xref>. (B) The PS mechanism inspires this predicted intracellular molecular mechanism based on the selective activation of C/EBPδ by LD LPS. (C) IFN-γ self-priming and cross-priming to LPS follows the AI and PS mechanisms. Network details are retrieved from the database IPA (@Ingenuity) as well as the experimental literature listed in <xref ref-type="supplementary-material" rid="pcbi.1002526.s011">Table S3</xref>. Dashed lines refer to indirect regulations involving autocrine signaling loops.</p>
          </caption>
          <graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002526.g008" xlink:type="simple"/>
        </fig>
        <p>Our analysis of priming and tolerance is not limited to LPS. Bagchi <italic>et al.</italic> showed that cross-priming may happen between specific TLRs <xref ref-type="bibr" rid="pcbi.1002526-Bagchi1">[41]</xref>. Ivashkiv and coworkers reported that IFN-γ can prime macrophage for an augmented response to a variety of stimulants, including bacterial LPS, virus, IFN-α/β and IFN-γ itself <xref ref-type="bibr" rid="pcbi.1002526-Hu1">[39]</xref>, <xref ref-type="bibr" rid="pcbi.1002526-Hu2">[40]</xref>. IFN-γ self-priming is similar to LPS self-priming: a low dose can prime for boosted expression of interferon-responsive genes. The priming mechanism as reported by Hu <italic>et al.</italic> resembles the AI strategy <xref ref-type="bibr" rid="pcbi.1002526-Hu3">[55]</xref>. Interferon-responsive genes such as IRF1 and IP-10 are transcriptionally induced by transcription factor STAT1, and are inhibited by SOCS1 through a negative feedback mechanism. Low dose IFN-γ (1 U/ml) is able to elevate the expression level of STAT1, preparing macrophage for a boosted activation of STAT1 (through phosphorylation and dimerization of STAT1) under the high dose IFN-γ stimulation. With STAT1 being active, however, the inhibitor SOCS1 cannot be expressed during the priming stage, resulting in an augmented expression of IRF-1 and IP-10 (<xref ref-type="fig" rid="pcbi-1002526-g008">Figure 8C</xref>). Furthermore, <xref ref-type="fig" rid="pcbi-1002526-g008">Figure 8C</xref> suggests a possible cross-priming between IFN-γ and TLR4 via a PS mechanism. Priming of macrophage by a low dose IFN-γ promotes STAT1 expression, which may synergistically cooperate with NFκB to give boosted cytokine expression to secondary stimulation by LPS <xref ref-type="bibr" rid="pcbi.1002526-Hu3">[55]</xref>, <xref ref-type="bibr" rid="pcbi.1002526-Schroder1">[56]</xref>. Further experimental studies are needed to confirm the prediction.</p>
      </sec>
      <sec id="s3c">
        <title>Limitations of three-node models and further theoretical studies</title>
        <p>Three-node models have been used to analyze functional network motifs in several contexts <xref ref-type="bibr" rid="pcbi.1002526-Ma1">[6]</xref>, <xref ref-type="bibr" rid="pcbi.1002526-Alon1">[7]</xref>, <xref ref-type="bibr" rid="pcbi.1002526-Yao1">[43]</xref>. The simplicity of three-node models allows a thorough search of the parameter space. However, the model should be viewed as a minimal system. A typical biochemical network surely has more than three nodes. Therefore each node or link in the three-node model is normally coarse-grained from more complex networks. The model parameters are also composite quantities. Three-node models are limited in their ability to generate certain dynamic features such as time delays. <xref ref-type="fig" rid="pcbi-1002526-g003">Figure 3A</xref> shows the backbone motifs of the three mechanisms we have identified. Further studies of models with additional nodes will be necessary to determine whether all of the links are necessary. For example, in <xref ref-type="fig" rid="pcbi-1002526-g008">Figure 8B</xref>, we cannot find evidence for IL-6 inhibiting C/EBPδ (either by direct or indirect links). This lack of evidence may indicate a missing link waiting for experimental confirmation, or it may indicate a limitation of the three-node model. The parameter search algorithm developed in this work can be applied to models with 4 or more nodes, although the search space grows rapidly with the number of nodes.</p>
        <p>Despite the above-mentioned limitations, we expect that the three priming mechanisms and the one tolerance mechanism discovered here are quite general, holding beyond the three-node model. We expect that the present work can serve as a basis for analyzing larger networks with more mechanistic details. As illustrated in <xref ref-type="fig" rid="pcbi-1002526-g008">Figure 8</xref>, motifs can be combined together in series or in parallel, and these combined structures may lead to new dynamic properties of functional importance.</p>
      </sec>
      <sec id="s3d">
        <title>Suggested experimental design</title>
        <p>Our analysis in <xref ref-type="fig" rid="pcbi-1002526-g006">Figure 6</xref> suggests that systematic studies of signal durations (T<sub>1</sub>, T<sub>2</sub> and T<sub>3</sub>) may reveal important details of the dynamics of priming and tolerance. For example, both relatively short (4 h, as the experiment in this paper) and longer priming duration (≥20 h) are exhibit priming effects in macrophages <xref ref-type="bibr" rid="pcbi.1002526-Henricson1">[25]</xref>. Relatively fast transcriptional regulators like NFκB and AP-1, as well as numerous signaling repressors such as PI3K and nuclear receptors, may be involved in intracellular priming motifs, inducing priming in response to short pretreatments. On the other hand, a longer pretreatment orchestrates more complex intercellular pathways whereby autocrine or paracrine signaling of cytokines (e.g. IL-10, IL-12 and type I IFNs) might dominate the induction of priming effects <xref ref-type="bibr" rid="pcbi.1002526-Shnyra1">[19]</xref>. Therefore, measurements of the full time spectrum are necessary to reveal different parts of the network contributing to priming/tolerance.</p>
        <p>Furthermore, our analysis predicts that priming networks may respond in two distinct fashions: monostable (transient super-induction of cytokine) or bistable (sustained super-induction of cytokines). Time-course measurements can distinguish between these two responses, keeping in mind that the bistable behavior predicted here is relative to the effective time-scale of the model. Each motif considered here is embedded in a larger network. Eventually, in a healthy organism pro-inflammatory cytokines have to be cleared out by some other slow processes that resolve the inflammation. On this longer time scale, the sustained induction of cytokines predicted by some of our models would be resolved.</p>
        <p>The analysis presented in <xref ref-type="fig" rid="pcbi-1002526-g002">Figure 2B</xref> suggests a plausible hypothesis to characterize underlying mechanisms of endotoxin priming. High throughput techniques can be used to identify genes and proteins that are significantly changed by low dose pretreatment. Likely candidates can be assayed during the course of a priming experiment, and the time-course data analyzed as in <xref ref-type="fig" rid="pcbi-1002526-g002">Figure 2B</xref> to identify the critical regulatory factors.</p>
        <p>Our analyses and simulations reveal that the priming effect is quite sensitive to system dynamics, <italic>i.e.</italic>, to parameter values and initial conditions. It is well documented that many biological control systems, especially those involving gene expression, are stochastic in nature. Consequently a population of seemingly identical cells may respond heterogeneously to a fixed experimental protocol. In this case, single-cell measurements may reveal cell-to-cell variations in priming and tolerance responses <xref ref-type="bibr" rid="pcbi.1002526-Lee1">[57]</xref>–<xref ref-type="bibr" rid="pcbi.1002526-Diercks1">[59]</xref>.</p>
        <p>Taken together, our integrated and systems analyses reconcile the intriguing paradigm of priming and tolerance in monocytes and macrophages. Given the significance and prevalence of this paradigm in immune cells to diverse stimulants other than LPS, our identified functional motifs will serve as potential guidance for future experimental works related to macrophage polarization as well as dynamic balance of immune homeostasis and pathogenesis of inflammatory diseases.</p>
      </sec>
    </sec>
    <sec id="s4" sec-type="materials|methods">
      <title>Materials and Methods</title>
      <sec id="s4a">
        <title>Mathematical description</title>
        <p>The following mathematical formalism is used to describe the dynamics of the three-node system,<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002526.e001" xlink:type="simple"/></disp-formula>where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002526.e002" xlink:type="simple"/></inline-formula>, and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002526.e003" xlink:type="simple"/></inline-formula>. Notice that <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002526.e004" xlink:type="simple"/></inline-formula> lies between 0 and 1 for all <italic>t</italic>. All variables and parameters are dimensionless. <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002526.e005" xlink:type="simple"/></inline-formula> is a generic “sigmoidal” function with steepness (slope at <italic>W<sub>j</sub></italic> = 0) that increases with <italic>σ<sub>j</sub></italic>. Each <italic>ω<sub>ji</sub></italic> is a real number in [-1, 1] with its absolute value denoting the strength of the regulation; <italic>ω<sub>ji</sub></italic>&gt;0 for the “activators” and <italic>ω<sub>ji</sub></italic>&lt;0 for “inhibitors” of node <italic>j</italic>. The sum, <italic>W<sub>j</sub></italic>, is the net activation or inhibition on node <italic>j</italic>, and <italic>ω<sub>j</sub></italic><sub>0</sub> determines whether node <italic>j</italic> is “on” or “off” when all input signals are 0. The parameters <italic>γ<sub>j</sub></italic> determine how quickly each variable approaches its goal value, <italic>G</italic>(σ<italic><sub>j</sub>W<sub>j</sub></italic>) for the present value of <italic>W<sub>j</sub></italic>. Because the magnitudes of the weights are bounded, |<italic>ω<sub>ji</sub></italic>|&lt;1, it is possible to do a thorough and systematic search of all possible weight matrices, even for networks of moderate complexity, <italic>e.g.</italic>, <italic>K</italic> ( = number of non-zero <italic>ω<sub>ji</sub></italic>'s)&lt;20. The formalism is close to that used by Vohradsky <xref ref-type="bibr" rid="pcbi.1002526-Vohradsky1">[60]</xref>, <xref ref-type="bibr" rid="pcbi.1002526-Weaver1">[61]</xref> and others <xref ref-type="bibr" rid="pcbi.1002526-Jaeger1">[62]</xref>, <xref ref-type="bibr" rid="pcbi.1002526-Perkins1">[63]</xref> previously. More detailed discussions and applications of the formalism can be found in <xref ref-type="bibr" rid="pcbi.1002526-Hong1">[64]</xref>–<xref ref-type="bibr" rid="pcbi.1002526-Tyson3">[66]</xref>.</p>
        <p>The model contains 18 parameters: 9 <italic>ω<sub>ji</sub></italic>'s, 3 <italic>γ<sub>j</sub></italic>'s, 3 σ<italic><sub>j</sub></italic>'s and 3 <italic>ω<sub>j</sub></italic><sub>0</sub>'s. By setting <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002526.e006" xlink:type="simple"/></inline-formula>, we fix the time scale of the model to be the response time of the output variable, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002526.e007" xlink:type="simple"/></inline-formula>. We set <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002526.e008" xlink:type="simple"/></inline-formula>, so that the response variable is close to <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002526.e009" xlink:type="simple"/></inline-formula> in the absence of input. We also chose <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002526.e010" xlink:type="simple"/></inline-formula> as a moderate value for the sigmoidicity of the output response. Apart from that, <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002526.e011" xlink:type="simple"/></inline-formula> is set to be <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002526.e012" xlink:type="simple"/></inline-formula> so that the <italic>x<sub>2</sub></italic> pathway is responsive to LD stimulation.</p>
      </sec>
      <sec id="s4b">
        <title>Monte Carlo sampling algorithm</title>
        <p>Our goal is to sample points in a 14-dimensional parameter space that is bounded and continuous. The sampling algorithm needs to search the parameter space thoroughly and generate sample parameter sets that are statistically unbiased and significant. Our strategy is a random walk based on the Metropolis Algorithm <xref ref-type="bibr" rid="pcbi.1002526-Metropolis1">[67]</xref> through parameter space according to the following rules:</p>
        <list list-type="order">
          <list-item>
            <p>Choose an initial parameter set <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002526.e013" xlink:type="simple"/></inline-formula> and determine its score: <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002526.e014" xlink:type="simple"/></inline-formula> if it is a “good” set, or <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002526.e015" xlink:type="simple"/></inline-formula> if it is not. (See <xref ref-type="supplementary-material" rid="pcbi.1002526.s012">Text S1</xref> for the definition of a good set of parameters for priming or for tolerance.)</p>
          </list-item>
          <list-item>
            <p>Generate parameter set <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002526.e016" xlink:type="simple"/></inline-formula> from <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002526.e017" xlink:type="simple"/></inline-formula> by <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002526.e018" xlink:type="simple"/></inline-formula>, where <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002526.e019" xlink:type="simple"/></inline-formula> specifies the maximum displacement per step, and <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002526.e020" xlink:type="simple"/></inline-formula> is a vector of random numbers with uniform distribution between −0.5 and 0.5.</p>
          </list-item>
          <list-item>
            <p>Compute <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002526.e021" xlink:type="simple"/></inline-formula>. If <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002526.e022" xlink:type="simple"/></inline-formula>, then accept the step from <italic>k</italic> to <italic>k</italic>+1. If <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002526.e023" xlink:type="simple"/></inline-formula>, then accept the step from <italic>k</italic> to <italic>k</italic>+1 with probability <italic>ρ</italic>. Otherwise, reject the step <italic>k</italic> to <italic>k</italic>+1.</p>
          </list-item>
          <list-item>
            <p>Update <italic>k</italic>. If <italic>k</italic> is larger than a maximum step number, stop. Otherwise return to step 1.</p>
          </list-item>
        </list>
        <p>We pursue this strategy in two stages. In stage 1, we set <inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002526.e024" xlink:type="simple"/></inline-formula> (see <xref ref-type="supplementary-material" rid="pcbi.1002526.s012">Text S1</xref>), so that the random walk has larger tendency to stay in “good” regions of parameter space, but can also jump out of a good region and searches randomly until it falls into another good region (which may be the same region it left). Stage 1 generates a random walk of 10<sup>9</sup> steps, which is sampled every 100 steps. From this sample of 10<sup>7</sup> parameter sets only the good ones are saved, giving a sample of ∼<inline-formula><inline-graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pcbi.1002526.e025" xlink:type="simple"/></inline-formula> good parameter sets. These data are then analyzed as described below:</p>
        <list list-type="order">
          <list-item>
            <p>The K-means algorithm is applied to identify possible clusters of good parameter sets in the 14-dimensional parameter space. The clustering result is then visualized through the first two principal components (which account for ∼60% of the data variance) under Principal Component Analysis.</p>
          </list-item>
          <list-item>
            <p>One parameter set is chosen from each possible cluster to serve as starting points for stage 2.</p>
          </list-item>
        </list>
        <p>Stage 2 is a repeat of stage 1 with <italic>ρ</italic> = 0. In this case the random walk never leaves a good region. The purpose of stage 3 is to generate a large sample of good parameter sets that may occupy different regions of parameter space. The random walks are sampled every 100 steps, generating 10<sup>6</sup> good parameter sets from each starting point. Each parameter set must pass an additional test for “biological relevance” (see <xref ref-type="supplementary-material" rid="pcbi.1002526.s012">Text S1</xref> for details) before further analysis.</p>
        <p>While the results reported in the main text are from one run of the search procedure, the whole procedure was repeated several times with random initial starting point in stage 1. The final results of these repeated runs agree with each other, confirming the convergence of our search procedure.</p>
      </sec>
      <sec id="s4c">
        <title>Discretization of continuous parameter matrix into topology matrix</title>
        <p>In order to analyze the topological feature of each priming/tolerance mechanism, one needs to map the continuous parameters <italic>ω<sub>ji</sub></italic> into a discretized topological matrix <italic>τ<sub>ji</sub></italic>. In the topological space, variables are only described by (−, 0, +) representing inhibition, no regulation and activation, respectively. A cut off value ( = 0.1) is used to perform the discretization, following the rules below:<disp-formula><graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002526.e026" xlink:type="simple"/></disp-formula></p>
      </sec>
      <sec id="s4d">
        <title>Experimental studies of LPS priming and tolerance</title>
        <p>Murine bone marrow derived macrophages from C57BL/6 wild type mice were harvested as described previously <xref ref-type="bibr" rid="pcbi.1002526-Maitra1">[53]</xref>. Cells were cultured in DMEM medium (Invitrogen) supplemented with 100 units/mL penicillin, 100 µg/mL streptomycin, 2 mM l-glutamine, and 10% fetal bovine serum (Hyclone) in a humidified incubator with 5% CO<sub>2</sub> at 37°C. Cells were treated with LPS (<italic>E. coli</italic> 0111:B4, Sigma) as indicated in the figure legend. RNAs were harvested using Trizol reagent (Invitrogen) as previously described <xref ref-type="bibr" rid="pcbi.1002526-Maitra1">[53]</xref>. Quantitative real-time reverse-transcription (RT)-PCR were performed as described <xref ref-type="bibr" rid="pcbi.1002526-Maitra2">[68]</xref>. The relative levels of <italic>IL-6</italic> message were calculated using the ΔΔCt method, using <italic>GAPDH</italic> as the internal control. The relative levels of mRNA from the untreated samples were adjusted to 1 and served as the basal control value.</p>
      </sec>
    </sec>
    <sec id="s5">
      <title>Supporting Information</title>
      <supplementary-material id="pcbi.1002526.s001" mimetype="image/tiff" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002526.s001" xlink:type="simple">
        <label>Figure S1</label>
        <caption>
          <p>Illustration of the two-stage Metropolis search procedure. (A) Schematic illustration of the two-stage Metropolis search method for priming/tolerance parameter sets. In the first stage one randomly searches the whole parameter space. K-means clustering algorithm identifies one or more clusters of the data. Then one performs a second Metropolis step to search thoroughly inside each cluster. (B) As a result, we got three priming set clusters with K-means clustering. By calculating the minimum volume bounding ellipsoid, we found that cluster 1 and 2 belong to a single region (Region I) whereas cluster 3 belong to a separate region (Region II).</p>
          <p>(TIF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pcbi.1002526.s002" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002526.s002" xlink:type="simple">
        <label>Figure S2</label>
        <caption>
          <p>Distribution of change in <italic>x</italic><sub>2</sub>'s initial condition prior to HD without or without priming treatment. Both PS and AI show considerable increase in <italic>x</italic><sub>2</sub> in the primed system. PDF: probability distribution function.</p>
          <p>(PDF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pcbi.1002526.s003" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002526.s003" xlink:type="simple">
        <label>Figure S3</label>
        <caption>
          <p>Statistical method used to identify backbone motifs from priming/tolerance data.</p>
          <p>(PDF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pcbi.1002526.s004" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002526.s004" xlink:type="simple">
        <label>Figure S4</label>
        <caption>
          <p>Parameter correlations highlight the backbone motifs of each priming mechanism: (A) Pathway Synergy, (B) Suppressor Deactivation, and (C) Activator Induction.</p>
          <p>(PDF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pcbi.1002526.s005" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002526.s005" xlink:type="simple">
        <label>Figure S5</label>
        <caption>
          <p>Typical time course and corresponding trajectory in the phase space. (A) bistable case of AI mechanism. (B) bistable case of SD mechanism. Refer to <xref ref-type="fig" rid="pcbi-1002526-g003">Figure 3</xref> of the main text for the time course trajectories in other cases.</p>
          <p>(PDF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pcbi.1002526.s006" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002526.s006" xlink:type="simple">
        <label>Figure S6</label>
        <caption>
          <p>Change in the robustness rank as a result of variations in the topology cut-off. SD datasets are used as an example. The robustness rank is calculated based on density (top panel) or sample frequency (lower panel) of the unique topologies. Changes in the robustness rank is compared with 10% (left column), 30% (center column), and 50% (right column) variation in the topology cut-off τ<sub>0</sub> = 0.1.</p>
          <p>(PDF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pcbi.1002526.s007" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002526.s007" xlink:type="simple">
        <label>Figure S7</label>
        <caption>
          <p>Topologies of the PS and AI mechanisms. (A) The topology density distribution for the PS mechanism. (B) Top six PS topologies and the backbone motif. (C) The topology density distribution for the AI mechanism. (D) Top six AI topologies and the backbone motif. Line widths are proportional to the mean value of samples of the corresponding topology. Dashed lines denote the additional links present in the top topologies but absent in the backbone motif.</p>
          <p>(PDF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pcbi.1002526.s008" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002526.s008" xlink:type="simple">
        <label>Figure S8</label>
        <caption>
          <p>Parameter correlation and compensation affects the robustness of the model. A) Correlation matrix calculated based on the samples of each priming mechanism. The <italic>p</italic>-value is smaller than 0.05 except where marked. B) The parameter compensation mechanism is illustrated by the 2D correlation histogram of the SD samples (left) and the corresponding connection diagrams (right).</p>
          <p>(PDF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pcbi.1002526.s009" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002526.s009" xlink:type="simple">
        <label>Table S1</label>
        <caption>
          <p>Criteria identifying priming and tolerance for a given parameter set.</p>
          <p>(PDF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pcbi.1002526.s010" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002526.s010" xlink:type="simple">
        <label>Table S2</label>
        <caption>
          <p>Parameter sets used to generate time course and phase-space trajectory in <xref ref-type="fig" rid="pcbi-1002526-g003">Figure 3</xref> and <xref ref-type="supplementary-material" rid="pcbi.1002526.s005">Figure S5</xref>.</p>
          <p>(PDF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pcbi.1002526.s011" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002526.s011" xlink:type="simple">
        <label>Table S3</label>
        <caption>
          <p>Experimental literatures supporting the network details in <xref ref-type="fig" rid="pcbi-1002526-g008">Figure 8</xref>.</p>
          <p>(PDF)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pcbi.1002526.s012" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pcbi.1002526.s012" xlink:type="simple">
        <label>Text S1</label>
        <caption>
          <p>Detailed explanation of parameter search algorithm, modeling methods and statistical analysis of motifs.</p>
          <p>(PDF)</p>
        </caption>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ack>
      <p>We thank Dr Xiaoyu Hu for helpful discussions.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="pcbi.1002526-Gordon1">
        <label>1</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Gordon</surname><given-names>S</given-names></name><name name-style="western"><surname>Martinez</surname><given-names>FO</given-names></name></person-group>             <year>2010</year>             <article-title>Alternative Activation of Macrophages: Mechanism and Functions.</article-title>             <source>Immunity</source>             <volume>32</volume>             <fpage>593</fpage>             <lpage>604</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Akira1">
        <label>2</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Akira</surname><given-names>S</given-names></name><name name-style="western"><surname>Takeda</surname><given-names>K</given-names></name></person-group>             <year>2004</year>             <article-title>Toll-like receptor signalling.</article-title>             <source>Nat Rev Immunol</source>             <volume>4</volume>             <fpage>499</fpage>             <lpage>511</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Medzhitov1">
        <label>3</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Medzhitov</surname><given-names>R</given-names></name><name name-style="western"><surname>Horng</surname><given-names>T</given-names></name></person-group>             <year>2009</year>             <article-title>Transcriptional control of the inflammatory response.</article-title>             <source>Nat Rev Immunol</source>             <volume>9</volume>             <fpage>692</fpage>             <lpage>703</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Lin1">
        <label>4</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Lin</surname><given-names>WW</given-names></name><name name-style="western"><surname>Karin</surname><given-names>M</given-names></name></person-group>             <year>2007</year>             <article-title>A cytokine-mediated link between innate immunity, inflammation, and cancer.</article-title>             <source>J Clin Invest</source>             <volume>117</volume>             <fpage>1175</fpage>             <lpage>1183</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Ezekowitz1">
        <label>5</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Ezekowitz</surname><given-names>RAB</given-names></name><name name-style="western"><surname>Hoffmann</surname><given-names>JA</given-names></name></person-group>             <year>1996</year>             <article-title>Innate immunity.</article-title>             <source>Curr Opin Immunol</source>             <volume>8</volume>             <fpage>1</fpage>             <lpage>2</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Ma1">
        <label>6</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>W</given-names></name><name name-style="western"><surname>Trusina</surname><given-names>A</given-names></name><name name-style="western"><surname>El-Samad</surname><given-names>H</given-names></name><name name-style="western"><surname>Lim</surname><given-names>WA</given-names></name><name name-style="western"><surname>Tang</surname><given-names>C</given-names></name></person-group>             <year>2009</year>             <article-title>Defining Network Topologies that Can Achieve Biochemical Adaptation.</article-title>             <source>Cell</source>             <volume>138</volume>             <fpage>760</fpage>             <lpage>773</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Alon1">
        <label>7</label>
        <element-citation publication-type="other" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Alon</surname><given-names>U</given-names></name></person-group>             <year>2007</year>             <source>An introduction to systems biology: Design principles of biological circuits</source>             <publisher-name>Chapman and Hall/CRC</publisher-name> <!--===== Restructure page-count as size[@units="page"] =====--><size units="page">320</size>           </element-citation>
      </ref>
      <ref id="pcbi.1002526-Tyson1">
        <label>8</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Tyson</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Chen</surname><given-names>KC</given-names></name><name name-style="western"><surname>Novak</surname><given-names>B</given-names></name></person-group>             <year>2003</year>             <article-title>Sniffers, buzzers, toggles and blinkers: dynamics of regulatory and signaling pathways in the cell.</article-title>             <source>Curr Opin Cell Biol</source>             <volume>15</volume>             <fpage>221</fpage>             <lpage>231</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-ShenOrr1">
        <label>9</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Shen-Orr</surname><given-names>SS</given-names></name><name name-style="western"><surname>Milo</surname><given-names>R</given-names></name><name name-style="western"><surname>Mangan</surname><given-names>S</given-names></name><name name-style="western"><surname>Alon</surname><given-names>U</given-names></name></person-group>             <year>2002</year>             <article-title>Network motifs in the transcriptional regulation network of Escherichia coli.</article-title>             <source>Nat Genet</source>             <volume>31</volume>             <fpage>64</fpage>             <lpage>68</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Milo1">
        <label>10</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Milo</surname><given-names>R</given-names></name><name name-style="western"><surname>Shen-Orr</surname><given-names>S</given-names></name><name name-style="western"><surname>Itzkovitz</surname><given-names>S</given-names></name><name name-style="western"><surname>Kashtan</surname><given-names>N</given-names></name><name name-style="western"><surname>Chklovskii</surname><given-names>D</given-names></name><etal/></person-group>             <year>2002</year>             <article-title>Network motifs: simple building blocks of complex networks.</article-title>             <source>Science</source>             <volume>298</volume>             <fpage>824</fpage>             <lpage>827</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Kholodenko1">
        <label>11</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Kholodenko</surname><given-names>BN</given-names></name></person-group>             <year>2006</year>             <article-title>Cell-signalling dynamics in time and space.</article-title>             <source>Nat Rev Mol Cell Biol</source>             <volume>7</volume>             <fpage>165</fpage>             <lpage>176</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Ma2">
        <label>12</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Ma</surname><given-names>W</given-names></name><name name-style="western"><surname>Lai</surname><given-names>L</given-names></name><name name-style="western"><surname>Ouyang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Tang</surname><given-names>C</given-names></name></person-group>             <year>2006</year>             <article-title>Robustness and modular design of the Drosophila segment polarity network.</article-title>             <source>Mol Syst Biol</source>             <volume>2</volume>             <fpage>70</fpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Gilchrist1">
        <label>13</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Gilchrist</surname><given-names>M</given-names></name><name name-style="western"><surname>Thorsson</surname><given-names>V</given-names></name><name name-style="western"><surname>Li</surname><given-names>B</given-names></name><name name-style="western"><surname>Rust</surname><given-names>AG</given-names></name><name name-style="western"><surname>Korb</surname><given-names>M</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4.</article-title>             <source>Nature</source>             <volume>441</volume>             <fpage>173</fpage>             <lpage>178</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Hume1">
        <label>14</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Hume</surname><given-names>DA</given-names></name><name name-style="western"><surname>Ravasi</surname><given-names>T</given-names></name><name name-style="western"><surname>Wells</surname><given-names>CA</given-names></name></person-group>             <year>2007</year>             <article-title>Systems biology of transcription control in macrophages.</article-title>             <source>BioEssays</source>             <volume>29</volume>             <fpage>1215</fpage>             <lpage>1226</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Tegner1">
        <label>15</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Tegner</surname><given-names>J</given-names></name><name name-style="western"><surname>Nilsson</surname><given-names>R</given-names></name><name name-style="western"><surname>Bajic</surname><given-names>VB</given-names></name><name name-style="western"><surname>Bjorkegren</surname><given-names>J</given-names></name><name name-style="western"><surname>Ravasi</surname><given-names>T</given-names></name></person-group>             <year>2006</year>             <article-title>Systems biology of innate immunity.</article-title>             <source>Cell Immunol</source>             <volume>244</volume>             <fpage>105</fpage>             <lpage>109</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Litvak1">
        <label>16</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Litvak</surname><given-names>V</given-names></name><name name-style="western"><surname>Ramsey</surname><given-names>SA</given-names></name><name name-style="western"><surname>Rust</surname><given-names>AG</given-names></name><name name-style="western"><surname>Zak</surname><given-names>DE</given-names></name><name name-style="western"><surname>Kennedy</surname><given-names>KA</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Function of C/EBP delta in a regulatory circuit that discriminates between transient and persistent TLR4-induced signals.</article-title>             <source>Nat Immunol</source>             <volume>10</volume>             <fpage>437</fpage>             <lpage>443</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Gardy1">
        <label>17</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Gardy</surname><given-names>JL</given-names></name><name name-style="western"><surname>Lynn</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Brinkman</surname><given-names>FSL</given-names></name><name name-style="western"><surname>Hancock</surname><given-names>REW</given-names></name></person-group>             <year>2009</year>             <article-title>Enabling a systems biology approach to immunology: focus on innate immunity.</article-title>             <source>Trends Immunol</source>             <volume>30</volume>             <fpage>249</fpage>             <lpage>262</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Hirohashi1">
        <label>18</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Hirohashi</surname><given-names>N</given-names></name><name name-style="western"><surname>Morrison</surname><given-names>DC</given-names></name></person-group>             <year>1996</year>             <article-title>Low-dose lipopolysaccharide (LPS) pretreatment of mouse macrophages modulates LPS-dependent interleukin-6 production in vitro.</article-title>             <source>Infect Immun</source>             <volume>64</volume>             <fpage>1011</fpage>             <lpage>1015</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Shnyra1">
        <label>19</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Shnyra</surname><given-names>A</given-names></name><name name-style="western"><surname>Brewington</surname><given-names>R</given-names></name><name name-style="western"><surname>Alipio</surname><given-names>A</given-names></name><name name-style="western"><surname>Amura</surname><given-names>C</given-names></name><name name-style="western"><surname>Morrison</surname><given-names>DC</given-names></name></person-group>             <year>1998</year>             <article-title>Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12.</article-title>             <source>J Immunol</source>             <volume>160</volume>             <fpage>3729</fpage>             <lpage>3736</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Hume2">
        <label>20</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Hume</surname><given-names>DA</given-names></name><name name-style="western"><surname>Underhill</surname><given-names>DM</given-names></name><name name-style="western"><surname>Sweet</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Ozinsky</surname><given-names>AO</given-names></name><name name-style="western"><surname>Liew</surname><given-names>FY</given-names></name><etal/></person-group>             <year>2001</year>             <article-title>Macrophages exposed continuously to lipopolysaccharide and other agonists that act via toll-like receptors exhibit a sustained and additive activation state.</article-title>             <source>BMC Immunol</source>             <volume>2</volume>             <fpage>11</fpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Biswas1">
        <label>21</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Biswas</surname><given-names>SK</given-names></name><name name-style="western"><surname>Lopez-Collazo</surname><given-names>E</given-names></name></person-group>             <year>2009</year>             <article-title>Endotoxin tolerance: new mechanisms, molecules and clinical significance.</article-title>             <source>Trends Immunol</source>             <volume>30</volume>             <fpage>475</fpage>             <lpage>487</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-West1">
        <label>22</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>West</surname><given-names>MA</given-names></name><name name-style="western"><surname>Heagy</surname><given-names>W</given-names></name></person-group>             <year>2002</year>             <article-title>Endotoxin tolerance: A review.</article-title>             <source>Crit Care Med</source>             <volume>30</volume>             <fpage>S64</fpage>             <lpage>S73</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-West2">
        <label>23</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>West</surname><given-names>MA</given-names></name><name name-style="western"><surname>Koons</surname><given-names>A</given-names></name></person-group>             <year>2008</year>             <article-title>Endotoxin tolerance in sepsis: concentration-dependent augmentation or inhibition of LPS-stimulated macrophage TNF secretion by LPS pretreatment.</article-title>             <source>J Trauma</source>             <volume>65</volume>             <fpage>893</fpage>             <lpage>898; discussion 898–900</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Zhang1">
        <label>24</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>XK</given-names></name><name name-style="western"><surname>Morrison</surname><given-names>DC</given-names></name></person-group>             <year>1993</year>             <article-title>Lipopolysaccharide-Induced Selective Priming Effects on Tumor-Necrosis-Factor-Alpha and Nitric-Oxide Production in Mouse Peritoneal-Macrophages.</article-title>             <source>J Exp Med</source>             <volume>177</volume>             <fpage>511</fpage>             <lpage>516</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Henricson1">
        <label>25</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Henricson</surname><given-names>BE</given-names></name><name name-style="western"><surname>Manthey</surname><given-names>CL</given-names></name><name name-style="western"><surname>Perera</surname><given-names>PY</given-names></name><name name-style="western"><surname>Hamilton</surname><given-names>TA</given-names></name><name name-style="western"><surname>Vogel</surname><given-names>SN</given-names></name></person-group>             <year>1993</year>             <article-title>Dissociation of lipopolysaccharide (LPS)-inducible gene expression in murine macrophages pretreated with smooth LPS versus monophosphoryl lipid A.</article-title>             <source>Infect Immun</source>             <volume>61</volume>             <fpage>2325</fpage>             <lpage>2333</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-MorenoNavarrete1">
        <label>26</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Moreno-Navarrete</surname><given-names>JM</given-names></name><name name-style="western"><surname>Manco</surname><given-names>M</given-names></name><name name-style="western"><surname>Ibanez</surname><given-names>J</given-names></name><name name-style="western"><surname>Garcia-Fuentes</surname><given-names>E</given-names></name><name name-style="western"><surname>Ortega</surname><given-names>F</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>Metabolic endotoxemia and saturated fat contribute to circulating NGAL concentrations in subjects with insulin resistance.</article-title>             <source>Int J Obes (Lond)</source>             <volume>34</volume>             <fpage>240</fpage>             <lpage>249</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Wiesner1">
        <label>27</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Wiesner</surname><given-names>P</given-names></name><name name-style="western"><surname>Choi</surname><given-names>SH</given-names></name><name name-style="western"><surname>Almazan</surname><given-names>F</given-names></name><name name-style="western"><surname>Benner</surname><given-names>C</given-names></name><name name-style="western"><surname>Huang</surname><given-names>W</given-names></name><etal/></person-group>             <year>2010</year>             <article-title>Low doses of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor kappa B and activator protein-1: possible mechanism for acceleration of atherosclerosis by subclinical endotoxemia.</article-title>             <source>Circ Res</source>             <volume>107</volume>             <fpage>56</fpage>             <lpage>65</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Kiechl1">
        <label>28</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Kiechl</surname><given-names>S</given-names></name><name name-style="western"><surname>Egger</surname><given-names>G</given-names></name><name name-style="western"><surname>Mayr</surname><given-names>M</given-names></name><name name-style="western"><surname>Wiedermann</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Bonora</surname><given-names>E</given-names></name><etal/></person-group>             <year>2001</year>             <article-title>Chronic Infections and the Risk of Carotid Atherosclerosis : Prospective Results From a Large Population Study.</article-title>             <source>Circulation</source>             <volume>103</volume>             <fpage>1064</fpage>             <lpage>1070</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Slofstra1">
        <label>29</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Slofstra</surname><given-names>S</given-names></name><name name-style="western"><surname>Cate</surname><given-names>H</given-names></name><name name-style="western"><surname>Spek</surname><given-names>CA</given-names></name></person-group>             <year>2006</year>             <article-title>Low dose endotoxin priming is accountable for coagulation abnormalities and organ damage observed in the Shwartzman reaction. A comparison between a single-dose endotoxemia model and a double-hit endotoxin-induced Shwartzman reaction.</article-title>             <source>Thromb J</source>             <volume>4</volume>             <fpage>13</fpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Nakamura1">
        <label>30</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Nakamura</surname><given-names>T</given-names></name><name name-style="western"><surname>Nitta</surname><given-names>H</given-names></name><name name-style="western"><surname>Ishikawa</surname><given-names>I</given-names></name></person-group>             <year>2004</year>             <article-title>Effect of low dose Actinobacillus actinomycetemcomitans lipopolysaccharide pretreatment on cytokine production by human whole blood.</article-title>             <source>J Periodontal Res</source>             <volume>39</volume>             <fpage>129</fpage>             <lpage>135</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Kobayashi1">
        <label>31</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Kobayashi</surname><given-names>K</given-names></name><name name-style="western"><surname>Hernandez</surname><given-names>LD</given-names></name><name name-style="western"><surname>Galan</surname><given-names>JE</given-names></name><name name-style="western"><surname>Janeway</surname><given-names>CA</given-names></name><name name-style="western"><surname>Medzhitov</surname><given-names>R</given-names></name><etal/></person-group>             <year>2002</year>             <article-title>IRAK-M is a negative regulator of toll-like receptor signaling.</article-title>             <source>Cell</source>             <volume>110</volume>             <fpage>191</fpage>             <lpage>202</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Brint1">
        <label>32</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Brint</surname><given-names>EK</given-names></name><name name-style="western"><surname>Xu</surname><given-names>D</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><name name-style="western"><surname>Dunne</surname><given-names>A</given-names></name><name name-style="western"><surname>McKenzie</surname><given-names>AN</given-names></name><etal/></person-group>             <year>2004</year>             <article-title>ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance.</article-title>             <source>Nat Immunol</source>             <volume>5</volume>             <fpage>373</fpage>             <lpage>379</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Sly1">
        <label>33</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Sly</surname><given-names>LM</given-names></name><name name-style="western"><surname>Rauh</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Kalesnikoff</surname><given-names>J</given-names></name><name name-style="western"><surname>Song</surname><given-names>CH</given-names></name><name name-style="western"><surname>Krystal</surname><given-names>G</given-names></name></person-group>             <year>2004</year>             <article-title>LPS-Induced Upregulation of SHIP Is Essential for Endotoxin Tolerance.</article-title>             <source>Immunity</source>             <volume>21</volume>             <fpage>227</fpage>             <lpage>239</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Foster1">
        <label>34</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Foster</surname><given-names>SL</given-names></name><name name-style="western"><surname>Hargreaves</surname><given-names>DC</given-names></name><name name-style="western"><surname>Medzhitov</surname><given-names>R</given-names></name></person-group>             <year>2007</year>             <article-title>Gene-specific control of inflammation by TLR-induced chromatin modifications.</article-title>             <source>Nature</source>             <volume>447</volume>             <fpage>972</fpage>             <lpage>978</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Chang1">
        <label>35</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Chang</surname><given-names>J</given-names></name><name name-style="western"><surname>Kunkel</surname><given-names>SL</given-names></name><name name-style="western"><surname>Chang</surname><given-names>CH</given-names></name></person-group>             <year>2009</year>             <article-title>Negative regulation of MyD88-dependent signaling by IL-10 in dendritic cells.</article-title>             <source>Proc Natl Acad Sci U S A</source>             <volume>106</volume>             <fpage>18327</fpage>             <lpage>18332</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-ElGazzar1">
        <label>36</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>El Gazzar</surname><given-names>M</given-names></name><name name-style="western"><surname>Yoza</surname><given-names>BK</given-names></name><name name-style="western"><surname>Hu</surname><given-names>JY</given-names></name><name name-style="western"><surname>Cousart</surname><given-names>SL</given-names></name><name name-style="western"><surname>McCall</surname><given-names>CE</given-names></name></person-group>             <year>2007</year>             <article-title>Epigenetic silencing of tumor necrosis factor alpha during endotoxin tolerance.</article-title>             <source>J Biol Chem</source>             <volume>282</volume>             <fpage>26857</fpage>             <lpage>26864</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Li1">
        <label>37</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Cousart</surname><given-names>S</given-names></name><name name-style="western"><surname>Hu</surname><given-names>J</given-names></name><name name-style="western"><surname>McCall</surname><given-names>CE</given-names></name></person-group>             <year>2000</year>             <article-title>Characterization of interleukin-1 receptor-associated kinase in normal and endotoxin-tolerant cells.</article-title>             <source>J Biol Chem</source>             <volume>275</volume>             <fpage>23340</fpage>             <lpage>23345</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Jacinto1">
        <label>38</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Jacinto</surname><given-names>R</given-names></name><name name-style="western"><surname>Hartung</surname><given-names>T</given-names></name><name name-style="western"><surname>McCall</surname><given-names>C</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name></person-group>             <year>2002</year>             <article-title>Lipopolysaccharide- and lipoteichoic acid-induced tolerance and cross-tolerance: distinct alterations in IL-1 receptor-associated kinase.</article-title>             <source>J Immunol</source>             <volume>168</volume>             <fpage>6136</fpage>             <lpage>6141</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Hu1">
        <label>39</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>X</given-names></name><name name-style="western"><surname>Chakravarty</surname><given-names>SD</given-names></name><name name-style="western"><surname>Ivashkiv</surname><given-names>LB</given-names></name></person-group>             <year>2008</year>             <article-title>Regulation of interferon and Toll-like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms.</article-title>             <source>Immunol Rev</source>             <volume>226</volume>             <fpage>41</fpage>             <lpage>56</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Hu2">
        <label>40</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>X</given-names></name><name name-style="western"><surname>Ivashkiv</surname><given-names>LB</given-names></name></person-group>             <year>2009</year>             <article-title>Cross-regulation of Signaling Pathways by Interferon-[gamma]: Implications for Immune Responses and Autoimmune Diseases.</article-title>             <source>Immunity</source>             <volume>31</volume>             <fpage>539</fpage>             <lpage>550</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Bagchi1">
        <label>41</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Bagchi</surname><given-names>A</given-names></name><name name-style="western"><surname>Herrup</surname><given-names>EA</given-names></name><name name-style="western"><surname>Warren</surname><given-names>HS</given-names></name><name name-style="western"><surname>Trigilio</surname><given-names>J</given-names></name><name name-style="western"><surname>Shin</surname><given-names>HS</given-names></name><etal/></person-group>             <year>2007</year>             <article-title>MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists.</article-title>             <source>J Immunol</source>             <volume>178</volume>             <fpage>1164</fpage>             <lpage>1171</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Yang1">
        <label>42</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>K</given-names></name><name name-style="western"><surname>Bai</surname><given-names>H</given-names></name><name name-style="western"><surname>Ouyang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Lai</surname><given-names>L</given-names></name><name name-style="western"><surname>Tang</surname><given-names>C</given-names></name></person-group>             <year>2008</year>             <article-title>Finding multiple target optimal intervention in disease-related molecular network.</article-title>             <source>Mol Syst Biol</source>             <volume>4</volume>             <fpage>228</fpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Yao1">
        <label>43</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Yao</surname><given-names>G</given-names></name><name name-style="western"><surname>Tan</surname><given-names>CM</given-names></name><name name-style="western"><surname>West</surname><given-names>M</given-names></name><name name-style="western"><surname>Nevins</surname><given-names>JR</given-names></name><name name-style="western"><surname>You</surname><given-names>LC</given-names></name></person-group>             <year>2011</year>             <article-title>Origin of bistability underlying mammalian cell cycle entry.</article-title>             <source>Mol Sys Biol</source>             <volume>7</volume>             <fpage>485</fpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Necela1">
        <label>44</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Necela</surname><given-names>BM</given-names></name><name name-style="western"><surname>Su</surname><given-names>W</given-names></name><name name-style="western"><surname>Thompson</surname><given-names>EA</given-names></name></person-group>             <year>2008</year>             <article-title>Toll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor gamma and nuclear factor-kappaB in macrophages.</article-title>             <source>Immunology</source>             <volume>125</volume>             <fpage>344</fpage>             <lpage>358</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Liew1">
        <label>45</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Liew</surname><given-names>FY</given-names></name><name name-style="western"><surname>Xu</surname><given-names>D</given-names></name><name name-style="western"><surname>Brint</surname><given-names>EK</given-names></name><name name-style="western"><surname>O'Neill</surname><given-names>LA</given-names></name></person-group>             <year>2005</year>             <article-title>Negative regulation of toll-like receptor-mediated immune responses.</article-title>             <source>Nat Rev Immunol</source>             <volume>5</volume>             <fpage>446</fpage>             <lpage>458</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Day1">
        <label>46</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Day</surname><given-names>J</given-names></name><name name-style="western"><surname>Rubin</surname><given-names>J</given-names></name><name name-style="western"><surname>Vodovotz</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chow</surname><given-names>CC</given-names></name><name name-style="western"><surname>Reynolds</surname><given-names>A</given-names></name><etal/></person-group>             <year>2006</year>             <article-title>A reduced mathematical model of the acute inflammatory response II. Capturing scenarios of repeated endotoxin administration.</article-title>             <source>J Theor Biol</source>             <volume>242</volume>             <fpage>237</fpage>             <lpage>256</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Vodovotz1">
        <label>47</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Vodovotz</surname><given-names>Y</given-names></name><name name-style="western"><surname>Constantine</surname><given-names>G</given-names></name><name name-style="western"><surname>Rubin</surname><given-names>J</given-names></name><name name-style="western"><surname>Csete</surname><given-names>M</given-names></name><name name-style="western"><surname>Voit</surname><given-names>EO</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>Mechanistic simulations of inflammation: current state and future prospects.</article-title>             <source>Math Biosci</source>             <volume>217</volume>             <fpage>1</fpage>             <lpage>10</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Riviere1">
        <label>48</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Riviere</surname><given-names>B</given-names></name><name name-style="western"><surname>Epshteyn</surname><given-names>Y</given-names></name><name name-style="western"><surname>Swigon</surname><given-names>D</given-names></name><name name-style="western"><surname>Vodovotz</surname><given-names>Y</given-names></name></person-group>             <year>2009</year>             <article-title>A simple mathematical model of signaling resulting from the binding of lipopolysaccharide with Toll-like receptor 4 demonstrates inherent preconditioning behavior.</article-title>             <source>Math Biosci</source>             <volume>217</volume>             <fpage>19</fpage>             <lpage>26</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-An1">
        <label>49</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>An</surname><given-names>GC</given-names></name><name name-style="western"><surname>Faeder</surname><given-names>JR</given-names></name></person-group>             <year>2009</year>             <article-title>Detailed qualitative dynamic knowledge representation using a BioNetGen model of TLR-4 signaling and preconditioning.</article-title>             <source>Math Biosci</source>             <volume>217</volume>             <fpage>53</fpage>             <lpage>63</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Taniguchi1">
        <label>50</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Taniguchi</surname><given-names>T</given-names></name><name name-style="western"><surname>Takaoka</surname><given-names>A</given-names></name></person-group>             <year>2001</year>             <article-title>A weak signal for strong responses: interferon-alpha/beta revisited.</article-title>             <source>Nat Rev Mol Cell Biol</source>             <volume>2</volume>             <fpage>378</fpage>             <lpage>386</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Takeda1">
        <label>51</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Takeda</surname><given-names>K</given-names></name><name name-style="western"><surname>Akira</surname><given-names>S</given-names></name></person-group>             <year>2004</year>             <article-title>TLR signaling pathways.</article-title>             <source>Semin Immunol</source>             <volume>16</volume>             <fpage>3</fpage>             <lpage>9</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Laird1">
        <label>52</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Laird</surname><given-names>MH</given-names></name><name name-style="western"><surname>Rhee</surname><given-names>SH</given-names></name><name name-style="western"><surname>Perkins</surname><given-names>DJ</given-names></name><name name-style="western"><surname>Medvedev</surname><given-names>AE</given-names></name><name name-style="western"><surname>Piao</surname><given-names>W</given-names></name><etal/></person-group>             <year>2009</year>             <article-title>TLR4/MyD88/PI3K interactions regulate TLR4 signaling.</article-title>             <source>J Leukoc Biol</source>             <volume>85</volume>             <fpage>966</fpage>             <lpage>977</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Maitra1">
        <label>53</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Maitra</surname><given-names>U</given-names></name><name name-style="western"><surname>Gan</surname><given-names>L</given-names></name><name name-style="western"><surname>Chang</surname><given-names>S</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name></person-group>             <year>2011</year>             <article-title>Low-Dose Endotoxin Induces Inflammation by Selectively Removing Nuclear Receptors and Activating CCAAT/Enhancer-Binding Protein {delta}.</article-title>             <source>J Immunol</source>             <volume>186</volume>             <fpage>4467</fpage>             <lpage>4473</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-vantVeer1">
        <label>54</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>van 't Veer</surname><given-names>C</given-names></name><name name-style="western"><surname>van den Pangaart</surname><given-names>PS</given-names></name><name name-style="western"><surname>van Zoelen</surname><given-names>MA</given-names></name><name name-style="western"><surname>de Kruif</surname><given-names>M</given-names></name><name name-style="western"><surname>Birjmohun</surname><given-names>RS</given-names></name><etal/></person-group>             <year>2007</year>             <article-title>Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model.</article-title>             <source>J Immunol</source>             <volume>179</volume>             <fpage>7110</fpage>             <lpage>7120</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Hu3">
        <label>55</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>X</given-names></name><name name-style="western"><surname>Herrero</surname><given-names>C</given-names></name><name name-style="western"><surname>Li</surname><given-names>W-P</given-names></name><name name-style="western"><surname>Antoniv</surname><given-names>TT</given-names></name><name name-style="western"><surname>Falck-Pedersen</surname><given-names>E</given-names></name><etal/></person-group>             <year>2002</year>             <article-title>Sensitization of IFN-[gamma] Jak-STAT signaling during macrophage activation.</article-title>             <source>Nat Immunol</source>             <volume>3</volume>             <fpage>859</fpage>             <lpage>866</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Schroder1">
        <label>56</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Schroder</surname><given-names>K</given-names></name><name name-style="western"><surname>Hertzog</surname><given-names>PJ</given-names></name><name name-style="western"><surname>Ravasi</surname><given-names>T</given-names></name><name name-style="western"><surname>Hume</surname><given-names>DA</given-names></name></person-group>             <year>2004</year>             <article-title>Interferon-gamma: an overview of signals, mechanisms and functions.</article-title>             <source>J Leukoc Biol</source>             <volume>75</volume>             <fpage>163</fpage>             <lpage>189</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Lee1">
        <label>57</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>TK</given-names></name><name name-style="western"><surname>Covert</surname><given-names>MW</given-names></name></person-group>             <year>2010</year>             <article-title>High-throughput, single-cell NF-[kappa]B dynamics.</article-title>             <source>Curr Op Genet Dev</source>             <volume>20</volume>             <fpage>677</fpage>             <lpage>683</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Ravasi1">
        <label>58</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Ravasi</surname><given-names>T</given-names></name><name name-style="western"><surname>Wells</surname><given-names>C</given-names></name><name name-style="western"><surname>Forest</surname><given-names>A</given-names></name><name name-style="western"><surname>Underhill</surname><given-names>DM</given-names></name><name name-style="western"><surname>Wainwright</surname><given-names>BJ</given-names></name><etal/></person-group>             <year>2002</year>             <article-title>Generation of diversity in the innate immune system: macrophage heterogeneity arises from gene-autonomous transcriptional probability of individual inducible genes.</article-title>             <source>J Immunol</source>             <volume>168</volume>             <fpage>44</fpage>             <lpage>50</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Diercks1">
        <label>59</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Diercks</surname><given-names>A</given-names></name><name name-style="western"><surname>Kostner</surname><given-names>H</given-names></name><name name-style="western"><surname>Ozinsky</surname><given-names>A</given-names></name></person-group>             <year>2009</year>             <article-title>Resolving cell population heterogeneity: real-time PCR for simultaneous multiplexed gene detection in multiple single-cell samples.</article-title>             <source>PLoS ONE</source>             <volume>4</volume>             <fpage>e6326</fpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Vohradsky1">
        <label>60</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Vohradsky</surname><given-names>J</given-names></name></person-group>             <year>2001</year>             <article-title>Neural network model of gene expression.</article-title>             <source>Faseb J</source>             <volume>15</volume>             <fpage>846</fpage>             <lpage>854</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Weaver1">
        <label>61</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Weaver</surname><given-names>DC</given-names></name><name name-style="western"><surname>Workman</surname><given-names>CT</given-names></name><name name-style="western"><surname>Stormo</surname><given-names>GD</given-names></name></person-group>             <year>1999</year>             <article-title>Modeling regulatory networks with weight matrices.</article-title>             <source>Pac Symp Biocomput</source>             <fpage>112</fpage>             <lpage>123</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Jaeger1">
        <label>62</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Jaeger</surname><given-names>J</given-names></name><name name-style="western"><surname>Surkova</surname><given-names>S</given-names></name><name name-style="western"><surname>Blagov</surname><given-names>M</given-names></name><name name-style="western"><surname>Janssens</surname><given-names>H</given-names></name><name name-style="western"><surname>Kosman</surname><given-names>D</given-names></name><etal/></person-group>             <year>2004</year>             <article-title>Dynamic control of positional information in the early Drosophila embryo.</article-title>             <source>Nature</source>             <volume>430</volume>             <fpage>368</fpage>             <lpage>371</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Perkins1">
        <label>63</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Perkins</surname><given-names>TJ</given-names></name><name name-style="western"><surname>Jaeger</surname><given-names>J</given-names></name><name name-style="western"><surname>Reinitz</surname><given-names>J</given-names></name><name name-style="western"><surname>Glass</surname><given-names>L</given-names></name></person-group>             <year>2006</year>             <article-title>Reverse engineering the gap gene network of Drosophila melanogaster.</article-title>             <source>PLoS Comput Biol</source>             <volume>2</volume>             <fpage>e51</fpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Hong1">
        <label>64</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Hong</surname><given-names>T</given-names></name><name name-style="western"><surname>Xing</surname><given-names>J</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name><name name-style="western"><surname>Tyson</surname><given-names>JJ</given-names></name></person-group>             <year>2011</year>             <article-title>A Mathematical Model for the Reciprocal Differentiation of T Helper 17 Cells and Induced Regulatory T Cells.</article-title>             <source>PLoS Comput Biol</source>             <volume>7</volume>             <fpage>e1002122</fpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Tyson2">
        <label>65</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Tyson</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Novak</surname><given-names>B</given-names></name></person-group>             <year>2010</year>             <article-title>Functional motifs in biochemical reaction networks.</article-title>             <source>Annu Rev Phys Chem</source>             <volume>61</volume>             <fpage>219</fpage>             <lpage>240</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Tyson3">
        <label>66</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Tyson</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Baumann</surname><given-names>WT</given-names></name><name name-style="western"><surname>Chen</surname><given-names>C</given-names></name><name name-style="western"><surname>Verdugo</surname><given-names>A</given-names></name><name name-style="western"><surname>Tavassoly</surname><given-names>I</given-names></name><etal/></person-group>             <year>2011</year>             <article-title>Dynamic modelling of oestrogen signalling and cell fate in breast cancer cells.</article-title>             <source>Nat Rev Cancer</source>             <volume>11</volume>             <fpage>523</fpage>             <lpage>532</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Metropolis1">
        <label>67</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Metropolis</surname><given-names>N</given-names></name><name name-style="western"><surname>Rosenbluth</surname><given-names>AW</given-names></name><name name-style="western"><surname>Rosenbluth</surname><given-names>MN</given-names></name><name name-style="western"><surname>Teller</surname><given-names>AH</given-names></name></person-group>             <year>1953</year>             <article-title>Equation of State Calculations by Fast Computing Machines.</article-title>             <source>The Journal of chemical physics</source>             <volume>21</volume>             <fpage>1087</fpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Maitra2">
        <label>68</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Maitra</surname><given-names>U</given-names></name><name name-style="western"><surname>Singh</surname><given-names>N</given-names></name><name name-style="western"><surname>Gan</surname><given-names>L</given-names></name><name name-style="western"><surname>Ringwood</surname><given-names>L</given-names></name><name name-style="western"><surname>Li</surname><given-names>L</given-names></name></person-group>             <year>2009</year>             <article-title>IRAK-1 contributes to lipopolysaccharide-induced reactive oxygen species generation in macrophages by inducing NOX-1 transcription and Rac1 activation and suppressing the expression of antioxidative enzymes.</article-title>             <source>J Biol Chem</source>             <volume>284</volume>             <fpage>35403</fpage>             <lpage>35411</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Nakagawa1">
        <label>69</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Nakagawa</surname><given-names>R</given-names></name><name name-style="western"><surname>Naka</surname><given-names>T</given-names></name><name name-style="western"><surname>Tsutsui</surname><given-names>H</given-names></name><name name-style="western"><surname>Fujimoto</surname><given-names>M</given-names></name><name name-style="western"><surname>Kimura</surname><given-names>A</given-names></name><etal/></person-group>             <year>2002</year>             <article-title>SOCS-1 participates in negative regulation of LPS responses.</article-title>             <source>Immunity</source>             <volume>17</volume>             <fpage>677</fpage>             <lpage>687</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Staples1">
        <label>70</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Staples</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Smallie</surname><given-names>T</given-names></name><name name-style="western"><surname>Williams</surname><given-names>LM</given-names></name><name name-style="western"><surname>Foey</surname><given-names>A</given-names></name><name name-style="western"><surname>Burke</surname><given-names>B</given-names></name><etal/></person-group>             <year>2007</year>             <article-title>IL-10 induces IL-10 in primary human monocyte-derived macrophages via the transcription factor Stat3.</article-title>             <source>J Immunol</source>             <volume>178</volume>             <fpage>4779</fpage>             <lpage>4785</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Benkhart1">
        <label>71</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Benkhart</surname><given-names>EM</given-names></name><name name-style="western"><surname>Siedlar</surname><given-names>M</given-names></name><name name-style="western"><surname>Wedel</surname><given-names>A</given-names></name><name name-style="western"><surname>Werner</surname><given-names>T</given-names></name><name name-style="western"><surname>Ziegler-Heitbrock</surname><given-names>HW</given-names></name></person-group>             <year>2000</year>             <article-title>Role of Stat3 in lipopolysaccharide-induced IL-10 gene expression.</article-title>             <source>J Immunol</source>             <volume>165</volume>             <fpage>1612</fpage>             <lpage>1617</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-deWaalMalefyt1">
        <label>72</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>de Waal Malefyt</surname><given-names>R</given-names></name><name name-style="western"><surname>Abrams</surname><given-names>J</given-names></name><name name-style="western"><surname>Bennett</surname><given-names>B</given-names></name><name name-style="western"><surname>Figdor</surname><given-names>CG</given-names></name><name name-style="western"><surname>de Vries</surname><given-names>JE</given-names></name></person-group>             <year>1991</year>             <article-title>Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.</article-title>             <source>J Exp Med</source>             <volume>174</volume>             <fpage>1209</fpage>             <lpage>1220</lpage>          </element-citation>
      </ref>
      <ref id="pcbi.1002526-Chen1">
        <label>73</label>
        <element-citation publication-type="journal" xlink:type="simple">             <person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>El Gazzar</surname><given-names>M</given-names></name><name name-style="western"><surname>Yoza</surname><given-names>BK</given-names></name><name name-style="western"><surname>McCall</surname><given-names>CE</given-names></name></person-group>             <year>2009</year>             <article-title>The NF-kappaB factor RelB and histone H3 lysine methyltransferase G9a directly interact to generate epigenetic silencing in endotoxin tolerance.</article-title>             <source>J Biol Chem</source>             <volume>284</volume>             <fpage>27857</fpage>             <lpage>27865</lpage>          </element-citation>
      </ref>
    </ref-list>
    
  </back>
</article>